Functional neuroanatomy of the noradrenergic locus coeruleus: Its roles in the regulation of arousal and autonomic function part II: Physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans

Current Neuropharmacology

Volumn 6, Issue 3, 2008, Pages 254-285

  Samuels, E R ^a   Szabadi, Elemer ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Aging; Alzheimer's disease; Anxiety; Arousal; Autonomic function; Locus coeruleus; Noxious stimuli; Parkinson's disease

Indexed keywords

12 ETHYLSULFONYL 5,8,8A,9,10,11,12,12A,13,13A DECAHYDRO 3 METHOXY 6H ISOQUINO[2,1 G][1,6]NAPHTHYRIDINE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 4 AMINOBUTYRIC ACID RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AUTORECEPTOR; CARBACHOL; CLONIDINE; CODEINE; DELOXAZINE; DEXMEDETOMIDINE; DIAZEPAM; IDAZOXAN; IMIDAZOLINE RECEPTOR; MODAFINIL; MORPHINE; MOXONIDINE; NEUROMELANIN; NISOXETINE; NORADRENALIN UPTAKE INHIBITOR; OPIATE AGONIST; OPIATE RECEPTOR; OXYCODONE; PRAMIPEXOLE; S 33005; SEDATIVE AGENT; TRAMADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; YOHIMBINE;

ALZHEIMER DISEASE; ANTINOCICEPTION; ANXIETY; AROUSAL; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BRAIN STEM; COMA; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; ENVIRONMENTAL TEMPERATURE; FEAR; FUNCTIONAL ANATOMY; HUMAN; HYPOTHERMIA; LOCUS CERULEUS; LOW DRUG DOSE; NEUROANATOMY; NEUROIMAGING; NOCICEPTIVE STIMULATION; NONHUMAN; NORADRENERGIC SYSTEM; PARKINSON DISEASE; PUPIL; REVIEW; SALIVATION; SEDATION; SIDE EFFECT; TEMPERATURE SENSITIVITY;

EID: 53249095795     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015908785777193     Document Type: Review

References (522)

1. Aantaa, R. (1991) Assessment of the sedative effects of deximedetomidine, an alpha 2-adrenoceptor agonist, with analysis of saccadic eye movements. Pharmacol. Toxicol., 68, 394-398.
2. Abdelmawla, A.H., Langley, R.W., Szabadi, E., Bradshaw, C.M. (1999) Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein. Br. J. Clin. Pharmacol., 48, 345-354.
3. Abduljawad, K.A.J., Langley, R.W., Bradshaw, C.M., Szabadi, E. (1997) Effects of clonidine and diazepam on the acoustic startle response and on its inhibition by 'prepulses' in man. J. Psychopharmacol., 11, 29-34.
4. Abduljawad, K.A.J., Langley, R-W., Bradshaw, C.M., Szabadi, E. (2001) Effects of clonidine and diazepam on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man. J. Psychopharmacol., 15, 237-242.
5. Abercrombie, E.D., Jacobs, B.L. (1987) Microinjected clonidine inhibits noradrenergic neurons of the locus coeruleus in freely moving cats. Neurosci. Lett., 76, 203-208.
6. Aghajanian, G.K., VanderMaelen, C.P. (1982) Alpha 2-adreno-ceptor- mediated hyperpolarization of locus coeruleas neurons: intracellular studies in vivo. Science, 15, 1394-1396.
7. Akaoka, H., Roussel, B., Lin, J.S., Chouvet, G., Jouvet, M. (1991) Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity. Neurosci. Lett., 123, 20-22.
8. Allen, R.C., Langman, M.E. (1976) The intra-ocular pressure response of conscious rabbits to clonidine. Invest. Ophthalmol., 15, 815-823.
9. Almeida, M.C., Steiner, A.A,, Coimbra, N.C., Branco, L.G.S. (2004) Thermoeffector neuronal pathways in fever: a study in rats showing a new role for the locus coeruleus. J. Physiol., 558, 283-294.
10. Amara, S.G., Kuhar, M.J. (1993) Neurotransmitter transporters: Recent progress. Ann. Rev. Neurosci., 16, 73-93.
11. Ameli, R., Ip, C., Grillon, C. (2001) Contextual fear-potentiated startle conditioning in humans: Replication and extension. Psychophysiology, 38, 383-390.
12. Arankowsky-Sandoval, G., Gold, P.E. (1995) Morphine-induced deficits in sleep patterns: Attenuation by glucose. Neurobiol. Learn. Mem., 64, 133-138.
13. Arima, K., Akashi, T. (1990) Involvement of the locus coeruleus in Pick's disease with or without Pick body formation. Acta Neuropathologica, 79, 629-633.
14. Arnulf, I., Konofal, E., Merino-Andreu, M., Houeto, J.L., Mesnage, V., Welter, M.L., Lacomblez, L., Golmard, J.L., Derenne, J.P., Agid, Y. (2002) Parkinson's disease and Sleepiness. Neurology, 58, 1019-1024.
15. Arya, D.K., Langley, R.W., Szabadi, E., Bradshaw, C.M. (1997) Comparison of the effects of high ambient temperature and clonidine on autonomic functions in man. Naunyn Schmiedeberg's Arch. Pharmacol., 355, 376-383.
16. Aston-Jones, G. (2005) Brain structures and receptors involved in alertness. Sleep. Med., 6 (Suppl. 1), S3-S7.
17. Aston-Jones, G., Bloom, F.E. (1981) Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci., 1, 876-886.
18. Aston-Jones, G., Chiang, C., Alexinsky, T. (1991) Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog. Brain Res., 88, 501-520.
19. Aston-Jones, G., Cohen, J.D. (2005) An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Ann. Rev. Neurosci., 28, 403-450.
20. Aston-Jones, G., Hirata, H., Akaoka, H. (1997) Local opiate withdrawal in locus coeruleus in vivo. Brain Res., 765, 331-336.
21. 2-recepor agonists evoke behavioural and electrocortical sleep in rats. Br. J. Pharmacol., 95, 860-866.
22. Bakes, A., Bradshaw, C.M., Szabadi, E. (1990) Attenuation of the pupillary light reflex in anxious patients. Br. J. Clin. Pharmacol., 30, 377-381.
23. Baloyannis, S.J., Costa, V., Baloyannis, I.S. (2006) Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease. J. Neurol. Sci., 248, 35-41.
24. Barrett, S.L., Bell, R., Watson, D., King, D.J. (2004) Effects of amisulpride, risperidone and chlorpromazine on auditory and visual latent inhibition, prepulse inhibition, executive function and eye movements in healthy volunteers. J. Psychopharmacol., 18, 156-172.
25. Barry, R.J., Rushby, J.A., Wallace, M.J., Clarke, A.R., Johnstone, S.J., Zlojutro, I. (2005) Caffeine effects on resting-state arousal. Clin. Neurophysiol., 116, 2693-2700.
26. Bay, K.D, Mamiya, K., Good, C.H., Skinner, R.D., Garcia-Rill, E. (2006) Alpha-2 adrenergic regulation of pedunculopontine nucleus neurons during development. Neuroscience, 141, 769-779.
27. Benarroch, E.E. (1992) Central neurotransmitters and neuromodulators in cardiovascular regulation. In: Bannister, R., Mathias, C.J. Eds. Autonomic Failure. 3rd Edition. Oxford, Oxford University Press, pp. 36-53.
28. Bennett, H.J., Semba, K. (1998) Immunohistochemical localization of caffeine-induced c-Fos protein expression in the rat brain. J. Comp. Neurol., 401, 89-108.
29. Berridge, C.W., Foote, S.L. (1991) Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J. Neurosci., 11, 3135-3145.
30. Berridge, C.W., Page, M.E., Valentino, R.J., Foote, S.L. (1993) Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. Neuroscience, 55, 381-393.
31. 2-adrenoceptors and modulated by serotonin. Neuropharmacology, 51, 146-153.
32. Bertrand, E., Lechowicz, W., Szpak, G.M., Dymecki, J. (1997) Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease. Folia Neuropathol., 35, 80-86.
33. Bezard, E., Brefel, C., Tison, F., Peyro-Saint-Paul, H., Ladure, P., Rascol, O., Gross, C.E. (1999) Effect of the α2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 23, 1237-1246.
34. Bickford-Wimer, P.C., Parfitt, K., Hoffer, B.J., Freedman, R. (1987) Desipramine and noradrenergic neurotransmission in aging: failure to respond in aged laboratory animals. Neuropharmacology, 26, 597-605.
35. Bing, G., Zhang, Y., Watanabe, Y., McEwen, B.S., Stone, E.A. (1994) Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra. Brain Res., 668, 261-265.
36. Bitsios, P., Philpott, A., Langley, R.W., Bradshaw, C.M., Szabadi, E. (1999) Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man. J. Psychopharmacol., 13, 226-234.
37. Bitsios, P., Prettyman, R., Szabadi, E. (1996) Changes in autonomic function with age: A study of pupillary kinetics in healthy young and old people. Age Ageing 25, 432-438.
38. Bitsios, P., Szabadi, E., Bradshaw, C.M. (1996) The inhibition of the light reflex by the threat of an electric shock: a potential laboratory model of human anxiety. J. Psychopharmacol., 10, 279-287.
39. Bitsios, P., Szabadi, E., Bradshaw, C.M. (1998) The effects of clonidine on the fear-inhibited light reflex. J. Psychopharmacol., 12, 137-145.
40. Bitsios, P., Szabadi, E., Bradshaw, C.M. (1998) Sensitivity of the fear- inhibited light reflex to diazepam. Psychopharmacology, 135, 93-98.
41. Bitsios, P., Szabadi, E., Bradshaw, C.M. (1999) Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man. Psychopharmacology, 143, 286-292.
42. Bitsios, P., Szabadi, E., Bradshaw, C.M. (2004) The fear-inhibited light reflex: importance of the anticipation of an aversive event. Int. J. Psychophysiol., 52, 87-95.
43. Bogdanski, D.F., Sulser, F., Brodie, B.B. (1961) Comparative action of reserpine, tetrabenazine and chlorpromazine on central parasympathetic activity: effects on pupillary size and lacrimation in rabbit and on salivation in dog. J. Pharmacol. Exp. Ther., 132, 176-182.
44. Bondareff, W., Mountjoy, C.Q., Roth, M., Rosser, M.N., Iverson, L.L., Reynolds, G.P., Hauser, D.L. (1987) Neuronal degeneration in locus coeruleus and cortical correlates of Alzheimer disease. Alzheimer Dis. Assoc. Disord., 1, 256-262.
45. Bostock, M.I. (1975) A clinical trial of clonidine (Catapres) in private practice. N. Z. Med. J., 81, 6-8.
46. Bousquet, P., Greney, H., Bruban, V., Schann, S., Ehrhardt, J.D., Monassier, L., Feldman, J. (2003) I(1) imidazoline receptors involved in cardiovascular regulation: where are we and where are we going? Ann. N.Y. Acad. Sci., 1009, 228-233.
47. Bousquet, P., Guertzenstein, P.G. (1973) Localization of the central cardiovascular action of clonidine. Br. J. Pharmacol., 49, 573-577.
48. Boutrel, B., Koob, G.F. (2004) What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep, 27, 1181-1194.
49. Braak, H., Del Tredici, K., Rüb, U., de Vos, R.A.I., Jansen Steur E.N.H., Braak, E. (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging, 24, 197-211.
50. Breen, L.A., Burde, R.M., Loewy, A.D. (1983) Brainstem connections to the Edinger-Westphal nucleus of the cat: a retrograde tracer study. Brain Res., 261, 303-306.
51. Bremner, J.D., Krystal, J.H., Southwick, S.M., Charney, D.S. (1996) Noradrenergic mechanisms in stress and anxiety: I. preclinical studies. Synapse, 23, 28-38.
52. Brodal, P. (2004) The Central Nervous System. Oxford, Oxford University Press.
53. Brownstein, M.J., Hoffman, B.J. (1994) Neurotransmitter transporters. Recent Prog. Horm. Res., 49, 27-42.
54. Bruce, M., Scott, N., Lader, M., Marks, V. (1986) The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects. Br. J. Clin. Pharmacol., 22, 81-87.
55. 2C receptors in the ventral tegmental area. Neuroscience, 146, 286-297.
56. Bullitt, E. (1990) Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J. Comp. Neurol., 296, 517-530.
57. Burke, W.J., Li, S.W., Schmitt, C.A., Xia, P., Chung, H.D., Gillespie, K.N. (1999) Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic, monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's disease: mechanism of neuron death. Brain Res., 816, 633-637.
58. Busch, C, Bohl, J., Ohm, T.G. (1997) Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus. Neurobiol. Aging, 18, 401-406.
59. Caldwell, J.A. Jr. (1996) Effects of operationally effective doses of dextroamphetamine on heart rates and blood pressures of army aviators. Mil. Med., 161, 673-678.
60. Cash, R., Dennis, T., L'Heureux, R., Raisman, R., Javoy-Agid, F., Scatton, B. (1997) Parkinson's disease and dementia: norepinephrine and dopamine in locus coeruleus. Neurology, 37, 42-46.
61. Cedarbaum, J.M., Aghajanian, G.K. (1978) Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J. Comp. Neurol., 178, 1-16.
62. Cespuglio, R., Rousset, C., Debilly, G., Rochat, C., Millan, M.J. (2005) Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the rat. Psychopharmacology (Berl.), 181, 639-652.
63. Chan-Palay, V. (1991) Alterations in the locus coerulcus in dementias of Alzheimer's and Parkinson's disease. Prog. Brain Res., 88, 625-630.
64. Chan-Palay, V., Asan, E. (1999) Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer's type and in Parkinson's disease with and without dementia and depression. J. Comp. Neurol., 287, 373-392.
65. Chan-Palay, V., Asan, E. (1989) Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression. J. Comp. Neurol., 287, 357-372.
66. Chapman, C.R., Oka, S., Bradshaw, D.H., Jacobson, R.C., Donaldson, G.W. (1999) Phasic pupil dilation response to noxious stimulation in normal volunteers: Relationship to brain evoked potentials and pain report. Psychophysiology, 36, 44-52.
67. Charney, D.S., Deutch, A. (1996) A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit. Rev. Neurobiol., 10, 419-446.
68. Charney, D.S., Redmond, D.E. Jr. (1983) Neurobiological mechanisms in human anxiety. Neuropharmacology, 22, 1531-1536.
69. Charney, D.S., Woods, S.W., Nagy, L.M., Southwick, S.M., Krystal, J.H., Heninger, G.R. (1990) Noradrenergic function in panic disorder. J. Clin. Psychiatry, 51 (Supp A), 5-11.
70. Chen, F.-J., Sara, S.J. (2007) Locus coeruleus activation by foot shock or electrical stimulation inhibits amygdala neurons. Neuroscience, 144, 472-481.
71. Chen, C.L., Yang, Y.R., Chiu, T.H. (1999) Activation of rat locus coeruleus neuron GABA(A) receptors by propofol and its potentiation by pentobarbital or alphaxalone. Eur. J. Pharmacol., 386, 201-210.
72. Cheng, S.-Y., Glazkova, D., Serova, L., Sabban, E.L. (2005) Effect of prolonged nicotine infusion on response of rat catecholamine biosynthetic enzymes to restraint and cold stress. Pharmacol. Biochem. Behav., 82, 559-568.
73. Chiu, T.H., Chen, M.J., Yang, Y.R., Yang, J.J., Tang, F.I. (1995) Actions of dexmedetomidine on rat locus coeruleus neurones: intracellular recording in vitro. Eur. J. Pharmacol., 285, 261-268.
74. Chou, T.C., Bjorkum, A.A., Gaus, S.E., Lu, J., Scammell, T.E., Saper, C.B. (2002) Afferents to the ventrolateral preoptic nucleus. J. Neurosci., 22, 977-990.
75. Christie, M.J. (1991) Mechanisms of opioid actions on neurons of the locus coeruleus. Prog. Brain Res., 88, 197-205.
76. Clifford, J.M., Day, M.D., Orwin, J.M. (1982) Reversal of clonidine induced miosis by the alpha 2-adrenoceptor antagonist RX 781094. Br. J. Clin. Pharmacol., 14, 99-101.
77. Coffman, J.D. (1992) α2-adrenergic and serotonergic receptors and forearm venous compliance in normal human subjects. J. Cardiovasc. Pharmacol., 19, 996-999.
78. Collier, T.J., Greene, J.G., Felten, D.L., Stevens, S.Y., Steece Collier, K. (2004) reduced cortical noradrenergic neurotransmission is associated with increased neophobia and impaired spatial memory in aged rats. Neurobiol. Aging, 25, 209-221.
79. Collingridge, G.L., James, T.A., MacLeod, N.K. (1979) Neurochemical and electrophysiological evidence for a projection from the locus coeruleus to the substantia nigra. J. Physiol, 290, 44P.
80. Corpas, I., de Andrés, I. (1991) Morphine effects in brainstem-transected cats: I. EEG and 'sleep-wakefulness' in the isolated forebrain. Behav. Brain Res., 44, 11-19.
81. Coupland, N.J., Bailey, J.E., Wilson, S.J., Potter, W.Z., Nutt, D.J. (1994) A pharmacodynamic study of the alpha 2-adrenergic receptor antagonist ethoxidazoxan in healthy volunteers. Clin. Pharmacol. Ther., 56, 420-429.
82. Craig, A.D. (1992) Spinal and trigeminal lamina I input to the locus coeruleus anterogradely labeled with Phaseolus vulgaris leucoagglutinin (PHA-L) in the cat and monkey. Brain Res., 584, 325-328.
83. Cui, Z.T., Zhang, T.M., Su, Z.H., Yen, W.W. (1988) Morphological changes in locus coeruleus of albino rats in relation to aging. Acta Anat. (Basel), 131, 207-209.
84. Cullen, L.K. (1996) Medetomidine sedation in dogs and cats: a review of its pharmacology, antagonism and dose. Br. Vet. J., 152, 519-535.
85. Cullinan, W.E., Herman, J.P., Battaglia, D.F., Akil, H., Watson, S.J. (1995) Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience, 64, 477-505.
86. Curet, O., De Montigny, C., Blier, P. (1992) Effect of desipramine and amphetamine on noradrenergic neurotransmission: electrophysiological studies in the rat brain. Eur. J. Pharmacol., 221, 59-70.
87. Curran, S., Wattis, J. (2000) Critical flicker fusion threshold: a potentially useful measure for the early detection of Alzheimer's disease. Hum. Psychopharmacol. Clin. Exp., 15, 103-112.
88. Curran, S., Wilson, S., Musa, S., Wattis, J. (2004) Critical flicker fusion threshold in patients with Alzheimer's disease and vascular dementia. Int. J. Geriatr. Psychiatry, 19, 575-581.
89. Curtis, A.L., Conti, E., Valentino, R.J. (1993) Cocaine effects on brain noradrenergic neurons of anesthetized and unanesthetized rats. Neuropharmacology, 32, 419-428.
90. Damasio, A.R. (1998) Emotion in the perspective of an integrated nervous system. Brain Res. Rev., 26, 83-86.
91. Danysz, W., Dyr, W., Plaznik, A., Kostowski, W. (1989) The effect of microinjections of clonidine into the locus coeruleus on cortical EEG in rats. Pol. J. Pharmacol. Pharm., 41, 45-50.
92. Davies, M.F., Tsui, J.Y., Flannery, J.A., Li, X., DeLorey, T.M., Hoffman, B.B. (2003) Augmentation of the noradrencigic system in alpha-2 adrenergic receptor deficient mice: anatomical changes associated with enhanced fear memory. Brain Res., 986, 157-165.
93. Davis, M. (1998) Are different parts of the extended amygdala involved in fear versus anxiety? Biol. Psychiatry, 44, 1239-1247.
94. Davis, M., Redmond, D.E., Baraban, J.M. (1979) Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology (Berl.), 65, 111-118.
95. de Andrés, I., Corpas, I. (1991) Morphine effects in brainstem-transected cats: II. Behavior and sleep of the decerebrate cat. Behav. Brain Res., 44, 21-26.
96. DeBattista, C., Doghramji, K., Menza, M.A., Rosenthal, M.H., Fieve, R.R.; Modafinil in Depression Study Group (2003) Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. J. Clin. Psychiatry, 4, 1057-1064.
97. Del Tredici, K., Rub, U., De Vos, R.A., Bohl, J.R., Braak, H. (2002) Where does Parkinson disease pathology begin in the brain? J. Neuropathol. Exp. Neurol., 61, 413-426.
98. De Maio, D., Johnson, F.N. (2000) The clinical efficacy of reboxetine in the treatment of depression. Rev. Contemp. Pharmacother., 11, 303-320.
99. De Sarro, G.B., Bagetta, G., Ascioti, C., Libri, V., Nistico, G. (1988) Microinfusion of clonidine and yohimbine into locus coeruleus alters EEG power spectrum: effects of aging and reversal by phosphatidylserine. Br. J. Pharmacol., 95, 1278-1286.
100. Deurveilher, S., Lo, H., Murphy, J.A., Burns, J., Semba, K. (2006) Differential c-Fos immunoreactivity in arousal-promoting cell groups following systemic administration of caffeine in rats. J. Comp. Neurol., 498, 667-689.
101. Dishman, R. K, Renner, K.J, White-Welkley, J.E, Burke,K.A, Bunnell, B.N. (2000) Treadmill exercise training augment brain norepinephrine response to familiar and novel stress. Brain Res. Bull., 52, 337-342.
102. 3H]dopamine release and alters the subjective properties of stimulants. Eur. J. Pharmacol., 568, 112-123.
103. Don, A.E., Debonnel, G. (2006) Effect of vagus nerve stimulation of serotonergic and noradrenergic transmission. J. Pharmacol. Exp. Ther., 318, 890-898.
104. Dortch-Carnes, J., Russell, K.R. (2006) Morphine-induced reduction of intraocular pressure and pupil diameter: role of nitric oxide. Pharmacology, 77, 17-24
105. Downs, J.L., Dunn, M.R., Borok, E., Shanabrough, M., Horvath, T.L., Kohama, S.G., Urbanski, H.F. (2007) Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque. Neurobiol. Aging, 28, 1286-1295.
106. Drolet, G., Gauthier, P. (1985) Peripheral and central mechanisms of the pressor response elicited by stimulation of the locus coeruleus in the rat. Can. J. Physiol. Pharmacol., 63, 599-605.
107. Eiden, L.E. (2000) The vesicular neurotransmitter transporters: current perspectives and future prospects. FASEB J., 14, 2396-2400.
108. Ekimova, I.V. (2003) Changes in the metabolic activity of neurons in the anterior hypothalamic nuclei in rats during hyperthermia, fever, and hypothermia. Neurosci. Behav. Physiol., 33, 455-460.
109. Elam, M., Svensson, T.H., Thoren, P. (1986) Locus coeruleus neurons and sympathetic nerves: activation by cutaneous sensory afferents. Brain Res., 366, 254-261.
110. Elrod, R., Peskind, E.R., DiGiacomo, L., Brodkin, K.I., Veith, R.C., Raskind, M.A. (1997) Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration. Am. J. Psychiatry, 154, 25-30.
111. España, R.A., Berridge, C.W. (2006) Organisation of noradrenergic efferents to arousal-related basal forebrain structures. J. Comp. Neurol., 496, 668-683.
112. Fabris, G., Anselmo-Franci, J.A., Branco, L.G. (1999) Role of nitric oxide in hypoxia-induced hyperventilation and hypothermia: participation of the locus coeruleus. Braz. J. Med. Biol. Res., 32, 1389-1398.
113. Featherby, T., Lawrence, A.J. (2004) Chronic cold stress regulates ascending noradrenergic pathways. Neuroscience, 127, 949-960.
114. Fernández-Pastor, B., Mateo, Y., Gómez-Urquijo, S., Meana, J.J. (2005) Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis. Psychopharmacology (Berl), 180, 570-579.
115. 2-adrenoceptors. Eur. J. Pharmacol., 442, 225-229.
116. Ferreira, J.J., Galitzky, M., Thalamus, C., Tiberge, M., Montastruc, U., Sampaio, C., Rascol, O. (2002) Effect of ropinirole on sleep onset: a randomised, placebo-controlled study in healthy volunteers. Neurology, 58, 460-462.
117. Fisone, G., Borgkvist, A., Usiello, A. (2004) Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol. Life Sci., 61, 857-872.
118. Fletcher, W.A., Sharpe, J.A. (1986) Saccadic eye movement dysfunction in Alzheimer's disease. Ann. Neurol., 20, 464-471.
119. Fletcher, W.A., Sharpe, J.A. (1989) Smooth pursuit dysfunction in Alzheimer's disease. Neurology, 38, 272-277.
120. Fodor, M., Görcs, T. J., Palkovits, M. (1992) Immunohistochemical study on the distribution of neuopeptides within the pontine tegmentum - particularly the parabrachial nuclei and the locus coeruleus of the human brain. Neuroscience, 46, 891-908.
121. Foote, S.L., Aston-Jones, G.S. (1995) Pharmacology and Physiology of Central Noradrenergic Systems. In: Bloom, F.E., Kupfer, D.J. Eds, Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press. pp. 335-345.
122. Foote, S.L., Aston-Jones, G., Bloom,, F.E. (1980) Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc. Natl. Acad. Sci. USA, 77, 3033-3037.
123. Foote, S.L., Berridge, C.W., Adams, L.M., Pineda, J.A. (1991) Electrophysiological evidence for the involvement of the locus coeruleus in alerting, orienting, and attending. Prog. Brain Res., 88, 521-532.
124. Foote, S.L., Bloom, F.E., Aston-Jones, G. (1983) Nucleus locus coeruleus: new evidence of anatomical and physiological specificity. Physiol. Rev., 63, 844-914.
125. Forst, H., Levy, R., Burns, A., Luthert, P., Cairns, N. (1994) Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease- a hypothesis. Pharmacopsychiatry, 27, 11-15.
126. Fort, P., Khateb, A., Pegna, A., Mühlethaler, M., Jones, B.E. (1995) Noradrenergic modulation of cholinergic nucleus basalis neurons demonstrated by in vitro pharmacological and immunohistochemical evidence in the guinea-pig brain. Eur. J. Neurosci., 7, 1502-1511.
127. Fyhrquist, F., Kurppa, K., Huuskonen, M. (1975) Plasma renin activity, blood pressure and sodium excretion during treatment with clonidine. Acta Med. Scan., 197, 457-461.
128. Gallopin, T., Luppi, P.H., Rambert, F.A., Frydman, A., Fort, P. (2004) Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep, 27, 19-25.
129. Gallopin, T., Luppi, P.H., Cauli, B. Urade, Y., Rossier, J., Hayaishi, O., Lanbolez, B., Fort, P. (2005) The endogenous somnogen adenosine excites a subset of sleep-promoting neurons via A2A receptors in the ventrolateral preoptic nucleus. Neuroscience, 134, 1377-1390.
130. Garcia, C., Schmitt, P., D'Aleo, P., Bittel, J., Cure, M., Pujol, J.F. (1994) Regional specificity of the long-term variation of tyrosine hydroxylase protein in rat catecholaminergic cell groups after chronic heat exposure. J. Neurochem., 62, 1172-1181.
131. Garzon, M., Tejero, S., Beneitez, A.M., de Andres, I. (1995) Opiate microinjections in the locus coeruleus area of the cat enhance slow wave sleep. Neuropeptides, 29, 229-239.
132. German, D.C., Liang, C.-L., Manaye, K.F., Lane, K., Sonsalia, P.K. (2000) Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons. Neuroscience, 101, 1063-1069.
133. German, D.C., Manaye, K.F., White, C.L. 3rd, Woodward, D.J., McIntire, D.D., Smith, W.K., Kalaria, R.N., Mann, D.M. (1992) Disease-specific patterns of locus coeruleus cell loss. Ann. Neurol., 32, 667-676.
134. German, D.C., Nelson, O., Liang, F., Liang, C.-L., Games, D. (2005) The PDAPP mouse model of Alzheimer's disease: locus coeruleus neuronal shrinkage. J. Comp. Neurol., 492, 469-476.
135. Gertler, R., Brown, H.C., Mitchell, D.H., Silvius, E.N. (2001) Dexmedetomidine: a novel sedative-analgesic agent. Proc. (Bayl. Univ. Med. Cent.), 14, 13-21.
136. Gesi, M., Soldani, P., Giorgi, F.S., Santinami, A., Bonaccorsi, I., Fornai, F. (2000) The role of locus coeruleus in the development of Parkinson's disease. Neurosci. Biobehav. Rev., 24, 655-668.
137. Gherezghiher, T., Koss, M.C. (1979) Clonidine mydriasis in the rat. Eur. J. Pharmacol., 57, 263-266.
138. Glue, P., Nutt, D. (1988) Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medication. J Psychopharmacol., 2, 119-137.
139. Glue, P., White, E., Wilson, S., Ball, D.M., Nutt, D.J. (1991) Pharmacology of saccadic eye movements in man. 2. Effects of the alpha 2-adrenoceptor ligands idazoxan and clonidine. Psychopharmacology (Berl.), 105, 368-373.
140. 2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat. Synapse, 36, 205-221.
141. Goddard, A.W., Charney, D.S., Germine, M., Woods, S.W., Heninger, G.R., Krystal, J.H., Goodman, W.K., Price, L.H. (1995) Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Biol. Psychiatry, 8, 74-85.
142. González, M.M., Debilly, G., Valatx, J.-L. (1998) Noradrenaline neurotoxin DSP-4 effects on sleep and brain temperature in the rat. Neurosci. Lett., 248, 93-96.
143. Gowing, L.R., Farrell, M., Ali, R.L., White, J.M. (2002) Alpha2-adrenergic agonists in opioid withdrawal. Addiction, 97, 49-58.
144. Graham, S.J., Scaife, J.C., Langley, R.W., Bradshaw, C.M., Szabadi, E., Xi, L., Crumley, T., Calder, N., Gottesdiener, K., Wagner, J.A. (2005) Effects of lorazepam on fear-potentiated startle responses in man. J. Psychopharmacol., 19, 249-258.
145. Grandoso, L., Pineda, J., Ugedo, L. (2004) Comparative study of the effects of desipramine and reboxetine on locus coeruleus neurons in rat brain slices. Neuropharmacology, 46, 815-823.
146. Grenhoff, J., Nisell, M., Ferre, S., Aston-Jones, G., Svensson, T.H. (1993) Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J. Neural Transm. Gen. Sect., 93, 11-25.
147. Grillon, C., Cordova, J., Levine, L.R., Morgan, C.A. (2003) Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans. Psychopharmacology (Berl.), 168, 446-454.
148. Grossman E, Rosenthal T, Peleg E, Holmes C, Goldstein DS (1993) Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J. Cardiovasc. Pharmacol., 22, 22-26.
149. Groves, D.A., Brown, V.J. (2005) Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci. Biobehav. Rev., 29, 493-500.
150. Grudzien, A., Shaw, P., Weintraub, S., Bigio, E., Mash, D.C., Mesulam, M.M. (2007) Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol. Aging, 28, 327-335.
151. Grunberger, J., Saletu, B., Linzmayer, L., Barbanoj, M.J. (1993) Clinical- pharmacological study with the two isomers (d-, 1-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: psychometric and psychophysiological evaluation. Methods Find. Exp. Clin. Pharmacol., 15, 313-328.
152. Gurtu, S., Pant, K.K., Sinha, J.N., Bhargava, K.P. (1984) An investigation into the mechanism of cardiovascular responses elicited by electrical stimulation of locus coeruleus and subcoeruleus in the cat. Brain Res., 301, 59-64.
153. Hajos, M., Engberg, G. (1990) A role of excitatory amino acids in the activation of locus coeruleus neurons following cutaneous thermal stimuli. Brain Res., 521, 325-328.
154. Haeusler, G. (1975) Cardiovascular regulation by central adrenergic, mechanisms and its alteration by hypotensive drugs. Circ. Res., 36, 223-232.
155. Hamburg, M., Tallman, J. (1981) Chronic morphine administration increases the apparent number of alpha2-adrenergic receptors in rat brain. Nature, 291, 493-495.
156. Hamilton, C. (1996) Chemistry, Mechanism of Action and Experimental Pharmacology of Moxonidine. In: van Zwieten, P.A., Julius, S., Hamilton, C.A., Prichard, B.N.C. Eds. The Il-imidazoline Receptor Agonist Moxonidine: A New Antihypertensive, 2nd Ed. London, Royal Society of Medicine. pp. 7-30.
157. Hamilton, M.J., Smith, P.R., Peck, A.W. (1983) Effects of bupropion, nomifensine and dexamphetamine on performance, subjective feelings, autonomic variables and electroencephalogram in healthy volunteers. Br. J. Clin. Pharmacol., 15, 367-374.
158. Han, S.K., Chong, W., Li, L.H., Lee, I.S., Murase, K., Ryu, P.D. (2002) Noradrenaline excites and inhibits GABAergic transmission in parvocellular neurons of rat hypothalamic paraventricular nucleus. J. Neurophysiol., 87, 2287-2296.
159. Handley, S.L., Thomas, K.V. (1978) On the mechanism of amphetamine- induced behavioural changes in the mouse. II. Effects of agents stimulating noradrenergic receptors. Arzneimittelforschung, 28, 834-837.
160. Harron, D.W., Hasson, B., Regan, M., McClelland, R.J., King, D.J. (1995) Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function. J. Cardiovasc. Pharmacol., 26 (Suppl 2), S48-S54.
161. Hauser, R.A., Gauger, L., McDowell Anderson, W., Zesiewicz, T.A. (2000) Pramipexole-induced somnolence and episodes of day-time sleep. Mov. Disord., 15, 658-663.
162. Haywood, J.R., Mifflin, S.W., Craig, T., Calderon, A., Hensler, J.G., Hinojosa-Laborde, C. (2001) gamma-Aminobutyric acid (GABA) - A function and binding in the paraventricular nucleus of the hypothalamus in chronic renal-wrap hypertension. Hypertension, 37, 614-618.
163. Head, G.A., Chan, C.K.S., Burke, S.L. (1998) Relationship between imidazoline and α 2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents. J. Auton. Nerv. Syst., 72, 163-169.
164. Head, G.A., Gundlach, A.L, Musgrave, I. F. (1998) Recent advances in imidazoline receptor research: ligands - localization and isolation - signalling - functional and clinical studies. J. Auton. Nerv. Syst., 72, 74-79.
165. Head, G.A., Mayorov, D.N. (2006) Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc. Hematol. Agents Med. Chem., 4, 17-32.
166. Heal, D.J., Cheetham, S.C., Butler, S.A., Gosden, J., Prow, M.R., Buckett, W.R. (1995) Receptor binding and functional evidence suggest that post-synaptic alpha 2-adrenoceptors in rat brain are of the alpha 2D subtype. Eur. J. Pharmacol., 277, 215-221.
167. Heal, D.J., Prow, M.R., Buckett, W.R. (1989) Clonidine produces mydriasis in conscious mice by activating centrail alpha 2-adrenoceptors. Eur. J. Pharmacol., 170, 11-18.
168. Heal, D.J., Prow, M.R., Buckett, W.R. (1989) Clonidine-induced hypoactivity and mydriasis in mice are respectively mediated via pre- and postsynaptic alpha 2-adrenoceptors in the brain. Eur. J. Pharmacol., 170, 19-28.
169. 2-adrenoceptors. Pharmacol. Biochem. Behav., 50, 219-224.
170. Heider, M., Schliebs, R., Rossner, S., Bigl, V. (1997) Basal fore-brain cholinergic immunolesion by 1921gG-saporin: evidence for a presynaptic location of subpopulations of alpha 2- and beta-adrenergic as well as 5- HT2A receptors on cortical cholinergic terminals. Neurochem. Res., 22, 957-966.
171. Heishman, S.J., Henningfield, J.E. (1991) Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans. Psychopharmacology (Berl.), 103, 436-442.
172. Heneka, M.T., Ramanathan, M., Jacobs, A.H., Dumitrescu-Ozimek, L., Bilkei-Gorzo, A., Debeir, T., Sastre, M., Galldiks, N., Zimmer, A., Hoehn, M., Heiss, W.-D., Klockgether, T., Staufenbiel, M. (2006) Locus coeruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J. Neurosci., 26, 1343-1354.
173. Herman, J.P., Ostrander, M.M., Mueller, N.K., Figueiredo, H. (2005) Limbic system mechanisms of stress regulation: hypothalamo-pituitary- adrenocortical axis. Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 1201-1213.
174. Hermann, D.M., Luppi, P.-H., Peyron, C., Hinckel, P., Jouvet, M. (1997) Afferent projections to die rat nuclei raphe magnus, raphe pallidus and reticularis gigantocellularis pars a demonstrated by iontophoretic application of choleratoxin (subunit b). J. Chem. Neuroanat., 13, 1-21.
175. Hey, J.A., Gherezghiher, T., Koss, M.C. (1985) Studies on the mechanism of clonidine-induced mydriasis in the rat. Naunyn-Schmiedebergs Arch. Pharmacol., 328, 258-263.
176. Hey, J.A., Ito, T., Koss, M.C. (1989) Mechanism of dexamphetamine- induced mydriasis in the anaesthetised rat. Br. J. Pharmacol., 96, 39-44.
177. 2-adrenoreceptor antagonists produce opposing mydriatic effects by a central action. J. Auton. Pharmacol., 8, 229-239.
178. Higgins, S.T., Rush, C.R., Bickel, W.K., Hughes, J.R., Lynn, M., Capeless, M.A. (1993) Acute behavioural and cardiac effects of cocaine and alcohol combinations in humans. Psychopharmacology (Berl.), 111, 285-294.
179. Hill, J.L., Zacny, J.P. (2000) Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers. Psychopharmacology (Berl.), 152, 31-39.
180. Hoefke, V.W., Kobinger, W. (1966) Pbarmakologische Wirkungen des 2- (2,6-dichlorphenylamino)-2-imidazolin-hydrochlorids, einer neuen, antihypertensive substanz. Arneimittelforschung, 16, 1038-1050.
181. Hoogendijk, W.J., Feenstra, M.G., Botterblom, M.H., Gilhuis, J., Sommer, I.E., Kamphorst, W., Eikelenbool, P., Swaab, D.F. (1999) Increased activity of surviving locus coeruleus neurons in Alzheimer's disease. Ann. Neurol., 45, 82-91.
182. Hossmann, V., Maling, T.J., Hamilton, C.A., Reid, J.L., Dollery, C.T. (1980) Sedative and cardiovascular effects of clonidine and nitrazepam. Clin. Pharmacol. Ther., 28, 167-176.
183. Hotson, J.R., Steinke, G.W. (1988) Vertical and horizontal saccades in aging and dementia. Neuro ophthalmology, 8, 267-273.
184. Hou, R.H., Freeman, C., Langley, R.W., Szabadi, E., Bradshaw, C.M. (2005) Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers. Psychopharmacology (Berl.), 181, 537-549.
185. Hou, Y.P., Manns, I.D., Jones, B.E. (2002) Immunostaining of cholinergic pontomesencephalic neurons for α1 versus α2 adrenergic receptors suggests different sleep-wake state activities and roles. Neuroscience, 114, 517-521.
186. Hou, R.H., Scaife, J., Freeman, C., Langley, R.W., Szabadi, E., Bradshaw, C.M. (2006) Relationship between sedation and pupillary function: comparison of diazepam and diphenhydramine. Br. J. Clin. Pharmacol., 61, 752-760.
187. Hou, R.H., Langley, R.W., Szabadi, E., Bradshaw, C.M. (2007) Comparison of diphenhydramine and modafinil on arousal and autonomic functions in healthy volunteers. J. Psychopharmacol., 21:567-578.
188. Hou, R.H., Samuels, E.R., Raisi, M., Langley, R.W., Szabadi, E., Bradshaw, C.M. (2006) Why patients with Alzheimer's disease may show increased sensitivity to tropicamide eye drops: Role of locus coeruleus. Psychopharmcology, 184: 95-106.
189. Hou, R.H., Samuels, E.R., Langley, R.W., Szabadi, E., Bradshaw, C.M. (2007) Arousal and the pupil: Why diazepam-induced sedation is not accompanied by miosis. Psychopharmacology (Berl.), 195: 41-59.
190. Huang, Z.-L., Urade, Y., Hayaishi, O. (2007) Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr. Opin. Pharmacol., 7, 33-38.
191. Hutton, J.T., Nagel, J.A., Loewenson, R.B. (1984) Eye tracking dysfunction in Alzheimer-type dementia. Neurology, 34, 99-102.
192. Hwang, K.-R., Chan, S.H.H., Chan, J.Y.H. (1998) Noradrenergic neurotransmission at PVN in locus coeruleus-induced baroreflex suppression in rats. Heart Circ. Physiol., 43, H1284-1292.
193. Ida, Y., Tanaka, M., Tsuda, A., Tsujimaru, S., Nagasaki, N. (1985) Attenuating effect of diazepam on stress-induced increases in noradrenaline turnover in specific brain regions of rats: antagonism by Ro 15-1788. Life Sci., 37, 2491-2498.
194. Ilbäck, N.-G., Siller, M., Stålhandsje, T. (2007) Evaluation of cardiovascular effects of caffeine using telemetric monitoring in the conscious rat. Food Chem. Toxicol., 45, 834-842.
195. Ishida, Y., Hashiguchi, H., Takeda, R., Ishizuka, Y., Mitsuyama, Y., Kannan, H., Nishimori, T., Nakahara, D. (2002) Conditioned-fear stress increases fos expression in monoaminergic and GABAergic neurons of the locus coeruleus and dorsal raphe nuclei. Synapse, 45, 46-51.
196. Ishida, Y., Shirokawa, T., Komatsu, Y., Isobe, K. (2001) Changes in cortical noradrenergic axon terminals of locus coeruleus neurons in aged F344 rats. Neurosci. Lett., 307, 197-199.
197. Ishida, Y., Shirokawa, T., Miyaishi, O., Komatsu, Y., Isobe, K. (2000) Age- dependent changes in projections from locus coeraleus to hippocampus dentate gyrus and frontal cortex. Eur. J. Neurosci., 12, 1263-1270.
198. Ishida, Y., Shirokawa, T., Miyaishi, O., Komatsu, Y., Isobe, K. (2001) Age-dependent changes in noradrenergic innervations of the frontal cortex in F344 rats. Neurobiol. Aging, 22, 283-286.
199. Ivanenko, A., Tauman, R., Gozal, D. (2003) Modafinil in the treatment of excessive daytime sleepiness in children. Sleep Med., 4, 579-582.
200. Ivanov, A., Aston-Jones, G. (1995) Extranuclear dendrites of locus coeruleus neurons: activation by glutamate and modulation of activity by alpha adrenoceptors. J. Neurophysiol., 74, 2427-2436.
201. Iversen, L.L., Rossor, M.N., Reynolds, G.P., Hills, R., Roth, M., Mountjoy, C.Q., Foote, S.L., Morrison, J.H., Bloom, F.E. (1983) Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type. Neurosci. Lett., 39, 95-100.
202. Jaanus, S.D. (1992) Ocular side effects of selected systemic drugs. Optom. Clin., 2, 73-96.
203. Jansen, A.S., Ter Horst, G.J., Mettenleiter, T.C., Loewy, A.D. (1992) CNS cell groups projecting to the submandibular parasympathetic preganglionic neurons in the rat: a retrograde transneuronal viral cell body labeling study. Brain Res., 572, 253-260.
204. 2-adrenoceptor antagonist, fluparoxan. Br. J. Clin. Pharmacol., 39, 477-483.
205. Jones, B.E. (2004) Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex. Prog. Brain Res., 145, 157-169.
206. Jones, B.E. (2005) From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol. Sci., 26, 578-586.
207. Jones, B.E., Moore, R.Y. (1977) Ascending projections of the locus coeruleus in the rat. II Autoradiographic study. Brain Res., 127, 25-53.
208. Jones, B.E., Yang, T.-Z. (1985) The efferent projections from the reticular formation and the locus coeruleus studies by anterograde and retrograde axonal transport in the rat. J. Comp. Neurol., 242, 56-92.
209. Jorm, C.M., Starnford, J.A. (1993) Actions of the hypnotic anaesthetic, dexmedetomidine, on noradrenaline release and cell firing in rat locus coeruleus slices. Br. J. Anaesth., 71, 447-449.
210. Jovanovic, T., Norrholm, S.D., Fiallos, A., Myers, K.M., Davis, M., Keyes, M., Jovanovic, S., Duncan, E.J. (2006) Contingency awareness and fear inhibition in a human fear-potentiated startle paradigm. Behav. Neurosci., 120, 995-1004.
211. Kaitin, K.I., Bliwise, D.L., Gleason, C., Nino-Murcia, G., Dement, W.C., Libet, B. (1986) Sleep disturbance produced by electrical stimulation of the locus coeruleus in a human subject. Biol. Psychiatry, 21, 710-716.
212. Kalsbeek, A., Garidou, M.L., Palm, I.F., Van Der Vliet, J., Simonneaux, V., Pevet, P., Buijs, R.M. (2000) Melatonin sees the light: blocking GABA- ergic transmission in the paraventricular nucleus induces daytime secretion of melatonin. Eur. J. Neurosci., 12, 3146-3154.
213. Kamimori, G.H., Penetar, D.M., Headley, D.B., Thorne, D.R., Otterstetter, R., Belenky, G. (2000) Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness. Eur. J. Clin. Pharmacol., 56, 537-544.
214. Kaniucki, M.D., Stefano, F.J., Perec, C.J. (1984) Clonidine inhibits salivary secretion by activation of postsynaptic alpha 2-receptors. Naunyn- Schmiedebergs Arch. Pharmacol., 326, 313-316.
215. Katz, R.J. (1979) Opiate stimulation increases exploration in the mouse. Int. J. Neurosci., 9, 213-215.
216. Kaur, S., Saxena, R.N., Mallick, B.N. (1997) GABA in locus coeruleus regulates spontaneous rapid eye movement sleep by acting on GABAA receptors in freely moving rats. Neurosci. Lett., 223, 105-108.
217. Keating, G.L., Rye, D.B. (2003) Where you least expect it: dopamine in the pons and modulation of sleep and REM-sleep. Sleep, 26, 788-789.
218. Kiernan, J.A. (2005) Barr's die human nervous system: an anatomical viewpoint. Maryland, USA, Lippincott Williams & Wilkins.
219. Kim, M.-A., Lee, H.S., Lee, B.Y., Waterhouse, B.D. (2004) Reciprocal connections between subdivisions of the dorsal raphe and the nuclear core of the locus coeruleus in the rat. Brain Res., 1026, 56-67.
220. Kimura, F., Nakamura, S. (1985) Locus coeruleus neurons in the neonatal rat: electrical activity and responses to sensory stimulation. Brain Res., 355, 301-305.
221. King, C., Masserano, J.M., Codd, E., Byrne, W.L. (1981) Effects of beta- endorphin and morphine on the sleep-wakefulness behavior of cats. Sleep, 4, 259-262.
222. nd Eds. London. Gaskell/Royal College of Psychiatrists, pp. 316-380.
223. Kiyohara, T., Miyata, S., Nakamura, T., Shido, O., Nakashima, T., Shibata, M. (1995) Differences in Fos expression in the rat brains between cold and warm ambient exposures. Brain Res. Bull., 38, 193-201.
224. Klemfuss, H., Adler, M.W. (1986) Autonomic mechanisms for morphine and amphetamine mydriasis in the rat. J. Pharmacol. Exp. Ther., 238, 788-793.
225. Knaggs, R.D., Crighton, I.M., Cobby, T.F., Fletcher, A.J.P., Hobbs, G.J. (2004) The pupillary effects of intravenous morphine, codeine, and tramadol in volunteers. Anesth. Analg., 99, 108-112.
226. Koch, M. (1999) The neurobiology of startle. Prog. Neurobiol., 59, 107-128.
227. Kocsis, B., Li, S., Hajos, M. (2007) Behavior-dependent modulation of hippocampal EEG activity by the selective norepinephrine reuptake inhibitor reboxetine in rats. Hippocampus, 17, 627-633.
228. Knob, G.F., Maldonado, R., Stimus, L. (1992) Neural substrates of opiate withdrawal. Trends Neurosci., 15, 186-191.
229. Koot, P., Deurenberg, P. (1995) Comparison of changes in energy expenditure and body temperatures after caffeine consumption. Ann. Nutr. Metab., 39, 135-142.
230. Korczyn, A.D., Maor, D. (1982) Central and peripheral components of morphine mydriasis in mice. Pharmacol. Biochem. Behav., 17, 897-899.
231. 2-adrenoceptor activation. J. Pharmacol. Methods, 15, 1-19.
232. Koss, M.C., San, L.C. (1976) Analysis of clonidine-induced mydriasis. Invest. Opthalmol., 15, 566-570.
233. Kumari, V., Cotter, P., Corr, P.J., Gray, J.A., Checkley, S.A. (1996) Effect of clonidine on the human acoustic startle reflex. Psychopharmacology (Berl.), 123, 353-360.
234. Kuskowski, M.A., Malone, S.M., Mortimer, J.A., Dysken, M.W. (1989) Smooth pursuit eye movements in dementia of the Alzheimer's type. Alzheimer Dis. Assoc. Disord., 3, 157-171.
235. Lamb, K., Bradshaw, C.M., Szabadi, E. (1983) The responsiveness of human eccrine sweat glands to choline and carbachol. Eur. J. Clin. Pharmacol., 24: 55-62.
236. Lane-Ladd, S.B., Pineda, J., Boundy, V.A., Pfeuffer, T., Krupinski, J., Aghajanian, G.K., Nestler, E.J. (1997) CREB (cAMP response element- binding protein) in the locus coeruleus: biochemical, physiological, and behavioural evidence for a role in opiate dependence. J. Neurosci., 17, 7890-7901.
237. 2- adrenoceptor agonist, on human pupillary reflexes during general anaesthesia. Br. J. Clin. Pharmacol., 51, 27-33.
238. Laubie, M., Schmitt, H. (1977) Sites of action of clonidine: centrally mediated increase in vagal tone, centrally mediated hypotensive and sympatho-inhibitory effects. Hypertens. Brain Mech., 47, 337-348.
239. Laurent, J.P., Mangold, M., Humbel, U., Haefely, W. (1983) Reduction by two benzodiazepines and pentobarbitone of the multi-unit activity in substantia nigra, hippocampus, nucleus locus coeruleus and nucleus raphe dorsalis of encephale isole rats. Neuropharmacology, 22, 501-511.
240. Laurie, D.J., Pratt, J.A. (l989) Local cerebral glucose utilization following subacute and chronic diazepam pre-treatment: differential tolerance. Brain Res., 504, 101-111.
241. Laverty, R., Taylor, K.M. (1969) Behavioural and biochemical effects of 2- (2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) on the central nervous system. Br. J. Pharmacol., 35, 253-264.
242. LeDoux, J. (1998) Fear and the brain: where have we been, and where are we going? Biol. Psychiatry, 44, 1229-1238.
243. Lee, C.R., McTavish, D., Sorkin, E.M. (1993) Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs, 46, 313-340.
244. Lees, A.J. (1993) Dopamine agonists in Parkinson's disease: a look at apomorphine. Fund. Clin. Pharmacol., 7, 121-128.
245. Leppävuori, A., Putkonen, P.T. (1980) Alpha-adrenoceptive influences on the control of the sleep-waking cycle in the cat. Brain Res., 193, 95-115.
246. Leslie, F.M., Loughlin, S.E., Sternberg, D.B., McGaugh, J.L., Young, L.E., Zornetzer, S.F. (1985) Noradrenergic changes and memory loss in aged mice. Brain Res., 359, 292-299.
247. Leung, N.K., Bradshaw, C.M., Szabadi, E. (1992) Effect of high ambient temperature on the kinetics of the pupillary light reflex in healthy volunteers. Br. J. Clin. Pharmacol., 33, 458-460.
248. Lewis, D.I., Coote, J.H. (1990) Excitation and inhibition of rat sympathetic preganglionic neurones by catecholamines. Brain Res., 530, 229-234.
249. Lewis, K.S., Han, N.H. (1997) Tramadol: a new centrally acting analgesic. Am. J. Health Syst. Pharm., 54, 643-652.
250. Liddell, B.J., Brown, K.J., Kemp, A.H., Barton, M.J., Das, P., Peduto, A., Gordon, E., Williams, L.M. (2005) A direct brainstemamygdala-cortical "alarm" system for subliminal signals of fear. NeuroImage, 24, 235-243.
251. Lightman, S.L., Todd, K., Everitt, B.J. (1984) Ascending noradrenergic projections from the brainstem: evidence for a major role in the regulation of blood pressure and vasopressin secretion. Exp. Brain Res., 55, 145-151.
252. Lipski, J.R., Kanjhan, B, Krusezeska, Smith, M. (1995) Barosensitive neurones in rostral ventrolateral medulla of a rat in vivo: morphological properties and relationship to C1 adrenergic neurons. Neuroscience, 69, 601-618.
253. Liu, X., Tang, X., Sanford, L.D. (2003) Fear-conditioned suppression of REM sleep: relationship to fos expression patterns in limbic and brainstem regions in BALB/cJ mice. Brain Res., 991, 1-17.
254. Loewenfeld, I.E. (1993) The Pupil: anatomy, physiology, and clinical applications. Detroit, Mich., Wayne State University Press.
255. Loewy, A.D., Araujo, J.C., Kerr, F.W.L. (1973) Pupillodilator pathways in the brain stem of the cat: anatomipal and electrophysiological identification of a central autonomic pathway. Brain Res., 60, 65-91.
256. Loewy, A. D., Spyer, K. M. (1990). Vagal preganglionic neurons. In: Loewy A D, Spyer, K.M. Eds. Central Regulation of Autonomic Functions. Oxford, Oxford University Press. pp. 68-87.
257. Lowenstein, O., Feinbeig, R., Loewenfeld, I.E. (1963) Pupillary movements during acute and chronic fatigue. Invest. Opthalmol., 2, 138-157.
258. Lu, J., Jhou, T.C., Saper, C.B. (2006) Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J. Neurosci., 26, 193-202.
259. Lyness, S.A., Zarow, C., Chui, H.C. (2003) Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol. Aging, 24, 1-23.
260. MacDonald, J.R., Hill, J.D., Tarnopolsky, M.A. (2002) Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. Neurology, 59, 1876-1880.
261. MacDougall, A.I., Addis, G.J., MacKay, N., Dymock, I.W., Turpie, A.G.G., Ballingall, D.L.K., MacLennan, W.J., Whiting, B., MacArthur, J.G. (1970) Treatment of hypertension with clonidine. Br. Med. J., 3, 440-442.
262. Madras, B.K., Xie, Z., Lin, Z., Jassen, A., Panas, H., Lynch, L., Johnson, R., Livni, E., Spencer, T.J., Bonab, A.A., Miller, G.M., Fischman, A.J. (2006) Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J. Pharmacol. Exp. Ther., 319, 561-569.
263. Maeda, T., Kitahama, K., Geffard, M. (1994) Dopaminergic innervation of rat locus coeruleus: a fight and electron microscope immunohistochemical study. Microsc. Res. Tech., 29, 211-218.
264. Makris, A.P., Rush, C.R., Frederich, R.C., Kelly, T.H. (2004) Wake- promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity. Appetite, 42, 185-195.
265. Manaye, K.F., McIntire, D.D., Mann, D.M.A., German, D.C. (1995) Locus coeruleus cell loss in the aging human brain: a non-random process. J. Comp. Neurol., 358, 79-87.
266. Mann, D.M., Yates, P.O., Hawkes, J. (1983) The pathology of the human locus coeruleus. Clin. Neuropathol., 2, l-7.
267. Mann, D.M., Yates, P.O., Marcyniuk, B. (1984) A comparison of changes in the nucleus basalis and locus coeraleus in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry, 47, 201-203.
268. Manus, I.D., Lee, M.G., Modirrousta, M., Hou, Y.P., Jones, B.E. (2003) Alpha 2 adrenergic receptors on GABA-ergic, putative sleep-promoting basal forebrain neurons. Eur. J. Neurosci., 18, 723-727.
269. Mantz, J. (1999) Dexmedetomidine. Drugs Today (Barc.), 35, 151-157.
270. Marcyniuk, B., Mann, D.M., Yates, P.O. (1989) The topography of nerve cell loss from the locus coeruleus in elderly persons. Neurobiol. Aging, 10, 5-9.
271. Marcyniuk, B., Mann, D.M., Yates, P.O., Ravindra, C.R. (1988) Topography of nerve cell loss from the locus coeraleus in middle aged persons with Down's syndrome. J. Neurol. Sci., 83, 15-24.
272. Marien, M.R., Colpaert, F.C., Rosenquist, A.C. (2004) Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res. Rev., 45, 38-78.
273. Marwaha, J., Kehne, J.H., Commissaris, R.L., Lakoski, J., Shaw, W., Davis, M. (1983) Spinal clonidine inhibits neural firing in locus coeruleus. Brain Res., 276, 379-383.
274. Masson, J., Sagn, C., Hamon, M., Mestikawy, S.E. (1999) Neurotransmitter transporters in the central nervous system. Pharmacol. Rev., 51, 439-464.
275. Matthews, K.L., Chen, C.P.L.-H., Esiri, M.M., Keene, J., Minger, S.L., Francis, P.T. (2002) Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol. Psychiatry, 51, 407-416.
276. Mavridis, M., Degryse, A.D., Lategan, A.J., Marien, M.R., Colpaert, F.C. (1991) Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl4-phenyl-1,2,3,6- tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease. Neuroscience, 41, 507-523.
277. Max, M.B., Schafer, S.C., Culnane, M., Dubner, R., Gracely, R.H. (1988) Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo. Clin. Pharmacol. Ther., 43, 363-371.
278. May, C.N., Ham, I.W., Heslop, K.E., Stone, F.A., Mathias, C.J. (1988) Intravenous morphine causes hypertension, hyperglycaemia and increases sympatho-adrenal outflow in conscious rabbits. Clin. Sci. (Lond.), 75, 71-77.
279. Mayer, A.F., Schroeder, C., Heusser, K., Tank, J., Diedrich, A., Schmieder, R.E., Luft, F.C., Jordan, J. (2006) Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans. Hypertension, 48, 120-126.
280. McCormick, D.A., Bal, T. (1997) Sleep and arousal: thalamocortical mechanisms. Ann. Rev. Neurosci., 20, 185-215.
281. McCormick,, D.A., Pape, H.C., Williamson, A. (1991) Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system. Prog. Brain Res., 88, 293-305.
282. McDougle, C.J., Krystal, J.H., Price, L.H., Heninger, G.R., Charney, D.S. (1995) Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbirie. Psychopharmacology (Berl.), 118, 127-135.
283. McLellan, T.M., Ducharme, M.B., Canini, F., Moroz, D., Bell, D.G., Baranski, J.V., Gil, V., Buguet, A., Radomski, M.W. (2002) Effect of modafinil on core temperature during sustained wakefulness and exercise in a warm environment. Aviat. Space Environ. Med., 73, 1079-1088.
284. Mehta, M.C., Jain, A.C., Billie, M. (2004) Effects of cocaine and caffeine alone and in combination on cardiovascular performance. An experimental hemodynamic and coronary flow reserve study in a canine model. Int. J. Cordiol., 97, 225-232.
285. Merrill, C.A., Jonsson, M.A.G., Minthon, L., Ejnell, H., Silander, H.C., Blennow, K., Karlsson, M., Nordlund, A., Rolstad, S., Warkentin, S., Ben- Menachem, E., Sjögren, M.J.C. (2006) Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year. J. Clin. Psychiatry, 67, 1171-1178.
286. Miller, C.D., Asbury, A.J., Brown, J.H. (1990) Pupillary effects of alfentanil and morphine. Br. J. Anaesth., 65, 415-417.
287. Mitler, M.M., O'Malley, M.B. (2005) Wake-promoting medications: efficacy and adverse effects. In: Kryger, M.H., Roth, T., Dement, W.C. Eds, Principles and Practice of Sleep Medicine, 4th Ed. Philadelphia, Elsevier Saunders. pp. 484-498.
288. 2-adrenergic receptors in basal forebrain and preoptic area express c-Fos during sleep. Neuroscience, 129, 803-810.
289. Mohler, H., Fritschy, J.M., Rudolph, U. (2002) A new benzodiazepine pharmacology. J. Pharmacol. Exp. Ther., 300, 2-8.
290. 2A-agonism in rabbits. In: Agmatine and Imidazolines: Their Novel Receptors and Enzymes. Ann. N.Y. Acad. Sci., 1009, 279-282.
291. Möller, H.-J. (2003) Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality. Prog. Neuropsychopharmacol. Biol. Psychiatry, 27, 1101-1111.
292. Montastruc, P., Berlan, M., Montastruc, J.L. (1989) Effects of yohimbine on submaxillary salivation in dogs. Br. J. Pharmacol., 98, 101-104.
293. Moore, R.Y., Bloom, F.E. (1979) Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Ann. Rev. Neurosci., 2, 113-168.
294. Morgan, C.A., Southwick, S.M., Grillon, C., Davis, M., Krystal, J.H., Charney, D.S. (1993) Yohimbine-facilitated acoustic startle reflex in humans. Psychopharmacology (Berl.), 110, 342-346.
295. Morilak, D.A., Fornal, C.A., Jacobs, B.L. (1987) Effects of physiological manipulations on locus coeruleus neuronal activity in freely moving cats. I. Thermoregulatory challenge. Brain Res., 422, 17-23.
296. Morley, M.J., Bradshaw, C.M., Szabadi, E. (1991) Effects of clonidine and yohimbine on the pupillary light reflex and carbachol-evoked sweating in healthy volunteers. Br. J. Clin. Pharmacol., 31, 99-101.
297. 8 in the rat lower brainstem. J. Comp. Neurol., 261, 193-208.
298. Murillo-Rodríguez, E., Haro, R., Palomero-Rivero, M., Millán-Aldaco, D., Drucker-Colín, R. (2007) Modafinil excites extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats. Behav. Brain Res., 176, 353-357.
299. Muzi, M., Goff, D.R., Kampine, J.P., Roerig, D.L., Ebert, T.J. (1992) Clonidine reduces sympathetic activity but maintains baroreflex responses in normotensive humans. Anesthesiology, 77, 864-871.
300. Myers, E.A., Banihashemi, L., Rinaman, L. (2005) The anxiogenic drug yohimbine activates central viscerosensory circuits in rats. J. Comp. Neurol., 492, 426-441.
301. Myers, K., Goulet, M., Rusche, J., Boismenu, R., Davis, M. (2004) Inhibition of fear potentiated startle in rats following peripheral administration of secretin. Psychopharmacology (Berl.), 172, 94-99.
302. Nahas, Z., Marangell, L.B., Husain, M.M., Rush, A.J., Sackeim, H.A., Lisanby, S.H., Martinez, J.M., George, M.S. (2005) Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J. Clin. Psychiatry, 66, 1097-1104.
303. 2-adenoceptors. Pharmacol. Res., 45, 407-412.
304. A receptors in an endogenous sleep pathway. Nat. Neurosci., 5, 979-984.
305. Nelson, L.E., Lu, J., Guo, T.Z., Saper, C.B., Franks, N.P., Maze, M. (2003). The α2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology, 98, 428-436.
306. Neophytou, S.I., Aspley, S., Butler, S., Beckett, S., Marsden, C.A. (2001) Effects of lesioning noradrenergic neurones in the locus coeruleus onconditioned and unconditioned aversive behaviour in the rat. Prog. Neuro Psychopharmacol. Biol. Psychiatry, 25, 1307-1321.
307. Newton, T.F., De La Garza, R., Kalechstein, A.D., Nestor, L. (2005) Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacol. Biochem. Behav., 82, 90-97.
308. 2A knockout mice. Br. J. Pharmacol., 141, 851-859.
309. Nieuwenhuys, R. (1985) Chemoarchitecture of the brain. Berlin, Springer- Verlag.
310. Nieves, A.V., Lang, A.E. (2002) Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil. Clin. Neuropharmacol., 25, 111-114.
311. Nishino, S., Mao, J., Sampathkumaran, R., Shelton, J., Mignot, E. (1998) Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res. Online, 1, 49-61.
312. Nistico, G., De Sarro, G.B. (1990) Altered responsiveness of central alpha 2- adrenoceptors in aging. Ann. Inst. Super. Sanita., 26, 69-74.
313. Nistico, G., De Sarro, G.B., Bagetta, G., Mollace, V. (1992) Altered sensitivity of alpha 2-adrenoceptors in the brain during aging in rats. Ann. N. Y. Acad Sci., 673, 206-213.
314. Nitz, D., Siegel, J.M. (1997) GABA release in the locus coeraleus as a function of sleep/wake state. Neuroscience, 78, 795-801.
315. Noordzij, M., Uiterwaal, C.S., Arends, L.R., Kok, F.J., Grobbee, D.E., Geleijnse, J.M. (2005) Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J. Hypertens., 23, 921-928.
316. Nygren, L.-G., Olson, L. (1977) A new major projection from locus coeruleus: the main source of noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord. Brain Res., 132, 85-93.
317. Ornstein, K., Milon, H., McRae-Degueurce, A., Alvarez, C., Berger, B., Würzner, H.P. (1987) Biochemical and radioautographic evidence for dopaminergic afferents of the locus coeruleus originating in the ventral tegmental area. J. Neurol. Transm., 70, 183-191.
318. Orrell, R.W., King, A.W., Hilton, D.A., Campbell, M.J., Lane, R.J., de Belleroche, J.S. (1995) Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J. Neurol., Neurosurg. Psychiatry, 59, 266-270.
319. Osaka, T., Matsumura, H. (1994) Noradrenergic inputs to sleep-related neurons in the preoptic area from the locus coeruleus and the ventrolateral medulla in the rat. Neurosci. Res., 19, 39-50.
320. Osterhout, C.A., Sterling, C.R., Chikaraishi, D.M., Tank, A.W. (2005) Induction of tyrosine hydroxylase in the locus coeruleus of transgenic mice in response to stress or nicotine treatment: lack of activation of tyrosine hydroxylase promoter activity. J. Neurochem., 94, 731-741.
321. Pacak, K., Armando, I., Fukuhara, K., Kvetnansky R., Palkovits, M., Kopin, I. J., Goldstein, D.S. (1992) Noradrenergic activation in the paraventricular nucleus during acute and chronic immobilization stress in rats: an in vivo microdialysis study. Brain Res., 589, 91-96.
322. Pacak, K., Palkovits, M., Kvetnansky, R., Fukuhara, K., Armando, I., Kopin, I. J., Goldstein, D. S. (1993) Effects of single or repeated immobolization on release of norepinephrine and its metabolites in the central nucleus of the amygdala in conscious rats. Neuroendocrinology, 57, 626-633.
323. Pacak, K., Palkovits, M., Kopin, I. J., Goldstein, D.S. (1995) Stress induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo micodialysis studies. Front. Neuroendocrinol., 16, 89-150.
324. Pacák, K., Palkovits, M. (2001) Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr. Rev., 22, 502-548.
325. Pack, A.I., Black, J.E., Schwartz, J.R.L., Matheson, J.K. (2001) Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am. J.Respir. Crit. Care Med., 164, 1675-1681.
326. Palkovits, M., Baffi, J.S., Dvori, S. (1995) Neuronal organisation of stress response. Pain-induced c-fos expression in brain stem catecholaminergic cell groups. Ann. N. Y. Acad. Sci., 771, 313-326.
327. Palkovits, M., Baffi, J.S., Pacák, K. (1997) Stress-induced Fos-like immunoreactivity in the pons and the medulla oblongata of rats. Stress, 1, 155-168.
328. Palkovits, M., Baffi, J.S., Pacák, K. (1999) The role of ascending neuronal pathways in stress-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats. J. Neuroendocrinol, 11, 529-539.
329. Parini, A., Moudanos, C.G., Pizzinat, N., Lanier, S.M. (1996) The elusive family of imidazoline binding sites. Trends Pharmacol. Sci., 17, 13-16.
330. Parvizi, J., Damasio, A.R. (2003) Neurochemical correlates of brainstem coma. Brain, 126, 1524-1536.
331. Patat, A., Rosenzweig, P., Miget, N., Allain, H., Gandon, J.-M. (1999) Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions in healthy sleep-deprived subjects. Fundam. Clin. Pharmacol., 13, 582-594.
332. Patt, S., Gerhard, L. (1993) A golgi study of human locus coerleus in normal brains and in Parkinson's disease. Neuropathol. Appl. Neurobiol., 19, 519-523.
333. Paus, S., Brecht, H.M., Koster, J., Seeger, G., Klockgether, T., Wullner, U. (2003) Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov. Disord., 18, 659-667.
334. Peacock, J.E., Henderson, P.D., Nimmo, W.S. (1988) Changes in pupil diameter after oral administration of codeine. Br. J. Anaesth., 61, 598-600.
335. Penetar, D., McCann, U., Thorne, D., Kamimori, G., Galinski, C., Sing, H., Thomas, M., Belenky, G. (1993) Caffeine reversal of sleep deprivation effects on alertness and mood. Psychopharmacology (Berl.), 112, 359-365.
336. Penttila, J., Helminen, A., Anttila, M., Hinkka, S., Scheinin, H. (2004) Cardiovascular and parasympathetic effects of dexmedetomidine in healthy subjects. Can. J. Physiol. Pharmacol., 82, 359-362.
337. Perrault, G.H., Depoortere, R., Morel, E., Sanger, D.J., Scatton, B. (1997) Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. J. Pharmacol. Exp. Ther., 280, 73-81
338. Perez, M.F., Nasif, F.J., Marchesini, G.R., Maglio, L.E., Ramirez, O.A. (2001) Hippocampus and locus coeruleus activity on rats chronically treated with diazepam. Pharmacol. Biochem. Behav., 69, 431-438.
339. Perl, D.P., Olanow, C.W., Calne, D. (1998) Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration. Ann. Neurol., 44 (Suppl 1), S19-S31.
340. Pezzone, M.A., Lee, W.-S., Hoffman, G.E., Pezzone, K.M., Rabin, B.S. (1993) Activation of brainstem catecholaminergic neurons by conditional and unconditional aversive stimuli as revealed by c-Fos immunoreactivity. Brain Res., 68, 310-318.
341. Phillips, M.A., Szabadi, E., Bradshaw, C.M. (2000). Comparison of the effects of clonidine and yohimbine on pupillary diameter at different illumination levels. Br. J. Clin. Pharmacol., 50, 65-68.
342. Phillips, M.A., Szabadi, E., Bradshaw, C.M. (2000) Comparison of the effects of clonidine and yohimbine on spontaneous pupillary fluctuations in healthy human volunteers. Psychopharmacology (Berl.), 150, 85-89.
343. Pickworth, W.B., Bunker, E., Welch, P., Cone, E. (1991) Intravenous buprenorphine reduces pupil size and the light reflex in humans. Life Sci., 49, 129-138.
344. Pickworth, W.B., Lee, H., Fudala, P.J. (1990) Buprenorphine-induced pupillary effects in human volunteers. Life Sci., 47, 1269-1277.
345. Pickworth, W.B., Welch, P., Henningfield, J.E., Cone, E.J. (1989) Opiate- induced pupillary effects in humans. Methods Find. Exp. Clin. Pharmacol., 11, 759-763.
346. Pigeau, R., Naitoh, P., Buguet, A., McCann, C., Baranski, J., Taylor, M., Thompson, M., Mack, I.I. (1995) Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J. Sleep Res., 4, 212-228.
347. Pirker, S., Schwarzer, C., Wieselthaler, A., Sieghart, W., Sperk, G. (2000) GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience, 101, 815-850.
348. Pitts, D.K., Marwah, J. (1986) Effects of cocaine on the electrical activity of single noradrenergic neurons from locus coeruleus. Life Sci., 38, 1229-1234.
349. Pitts, D.K., Marwah, J. (1987) Reciprocal pre- and postsynaptic actions of cocaine at a central noradrenergic synapse. Exp. Neurol., 98, 518-528.
350. Pitts, D.K., Marwab, J. (1987) Electrophysiological actions of cocaine on noradrenergic neurons in rat locus coeruleus. J. Pharmacol. Exp. Ther., 240, 345-351.
351. Pitts, D.K., Marwah, J. (1988) Cocaine-elicited mydriasis in the rat: pharmacological comparison to clonidine, D-amphetamine and desipramine. J. Pharmacol. Exp. Ther., 247, 815-823.
352. Pozzessere, G., Valle, E., Rossi, P., Petrucci, B., Ambrosini, A., D'Alessio, M., Pierelli, F., Giacomini, P. (1996) Pupillometric evaluation and analysis of light reflex in healthy subjects as a tool to study autonomic nervous system changes with aging. Aging (Milano), 8, 55-60.
353. Prettyman, R., Bitsios, P., Szabadi, E. (1997) Altered pupillary size and darkness and light reflexes in Alzheimer's discase. J. Neurol. Neurosurg. Psychiatry, 62, 665-668.
354. Rajkowski, J., Kubiak, P., Aston-Jones, G. (1993) Correlations between locus coeruleus (LC) neural activity, pupil diameter and behaviour in monkey support a role of LC in attention. Abstr. Soc. Neurosci., 19, 974.
355. Rajkowski, J., Kubiak, P., Aston-Jones, G. (1994) Locus coeruleus activity in monkey: phasic and tonic changes are associated with altered vigilance. Brain Res. Bull., 35, 607-616.
356. Rajput A.H., Uitti, R.J., Sudhakar, S., Rozdilsky, B. (1989) Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei. Ann. Neurol., 25, 602-606.
357. Ramesh, V., Kumar, V.M. (1998) The role of alpha-2 receptors in the media preoptic area in the regulation of sleep-wakefulness and body temperature. Neuroscience, 85, 807-817.
358. Rammohan, K.W., Rosenberg, J.H., Lynn, D.J., Blumenfeld, A.M., Pollak, C.P., Nagaraja, H.N. (2002) Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J. Neurol. Neurosurg. Psychiatry, 72, 179-183.
359. Rasmussen, K., Aghajanian, G.K. (1990) Serotonin excitation of facial motoneurons: receptor subtype characterization. Synapse, 5, 324-332.
360. Rasmussen, K., Jacobs, B.L. (1986) Single unitactivity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies. Brain Res., 23, 335-344.
361. Rasmussen, K., Morilak, D.A., Jacobs, B.L. (1986) Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Res., 371, 324-334.
362. Ravanelli, M.I.B., Almeida, M.C., Branco, L.G.S. (2007) Role of the locus coeruleus carbon monoxide pathway in endotoxin fever in rats. Pflugers Arch. Eur. J. Physiol., 453, 471-476.
363. Redmond, D.E. (1987) Studies of the nucleus locus coeruleus in monkeys and hypotheses for neuropsychopharmacology. In: Meltzer, H.Y. Ed, Psychopharmacology: The Third Generation of Progress. New York, Raven Press. pp. 467-974.
364. Redmond, D.E., Huang, Y.H. (1979) New evidence for a locus coeruleus- norepinephrine connection with anxiety. Life Sci., 25, 2149-2162.
365. Redmond, D.E., Huang, Y.H., Snyder, D.R., Maas, J.W. (1976) Behavioral effects of stimulation of the locus coeruleus in the stumptail monkey (macaca arctoldes). Brain Res., 116, 502-507.
366. Reid, J.L., Lewis, P.J., Meyers, M.G. (1975) Role of central dopaminergic mechanisms in piribedil and clonidine induced hypothermia in the rat Neuropharmacology, 14, 215-220.
367. Remy, P., Doder, M., Lees, A., Turjanski, N., Brooks, D. (2005) Depression in Parkinson's disease: loss of depamine and noradrenaline innervation in the limbic system. Brain, 128, 1314-1322.
368. Riddle, E.L., Fleckenstein, A.E., Hanson, G.R (2005) Role of monoamine transporters in modiating psychostimulant effects. AAPS J, 7, E847-E851.
369. Risbrough, V.B., Brodkin, J.D., Geyer, M.A. (2003) GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice. Neuropsychophannacology, 28, 654-663.
370. Rosenthal, M.H., Bryant S.L. (2004) Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia. Clin. Neuropharmacol., 27, 38-43.
371. Roth, J.D., Rowland, N.E. (1998) Efficacy of administration of dexfenfluramine and pentermine, alone and in combination, on ingestive behavior and body weight in rats. Psychopharmacology (Berl.), 137, 99-106.
372. Rüb, U., Schultz, C., Del Tredici, K., Braak, H. (2001) Early involvement of the tegmentopontine reticular nucleus during the evolution of Alzheimer's disease-related cytoskeletal pathology. Brain Res., 908, 107-112.
373. Rye, D.B., Jankovic, J. (2002) Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology, 58, 341-346.
374. Sajedianfard, J., Khatami, S., Semnanian, S., Naghdi, N., Jorjani, M. (2005) in vivo measurement of noradrenaline in the locus coerulcus of rats during the formalin test: a microdialysis study. Eur. J. Pharm., 512, 153-156.
375. Sakai, K., Salvert, D., Touret, M., Jouvet, M. (1977) Afferent connections of the nucleus raphe dorsalis in the cat as visualized by the horseradish peroxidase technique. Brain Res., 137, 11-35.
376. Salchner, P., Sartori, S.B., Sinner, C., Wigger, A., Frank, E., Landgraf, R., Singewald, N. (2006) Airjet and FG-7142-induced fos expression differs in rats selectively bred for high and low anxiety-related behavior. Neuropharmacology, 50, 1048-1058.
377. Samuels, E.R., Hou, R.H., Langley, R.W., Szabadi, E., Bradshaw, C.M. (2006) Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers. J. Psychopharmacol., 20, 756-770.
378. Samuels, E.R., Hou, R.H., Langley, R.W., Szabadi, E., Bradshaw, C.M. (2006) Comparison of amisulpride and pramipexole on alertness, autonomic and endocrine functions in healthy volunteers. Psychopharmacology (Berl.), 187, 498-510.
379. Samuels, E.R., Hou, R.H., Langley, R.W., Szabadi, E., Bradshaw, C.M. (2007) Modulation of the acoustic startle response by the level of arousal: comparison of clonidine and modafinil in healthy volunteers. Neuropsychopharmacology, 32:2405-2421.
380. Samuels, E.R., Hou, R.H., Langley, R.W., Szabadi, E., Bradshaw, C.M. (2007) Comparison of pramipexole with and without domperidone co- administration on alertness, autonomic, and endocrine functions in healthy volunteers. Br. J. Clin. Pharmacol., 64, 591-602.
381. 1D adrenergic receptor messenger RNA in oxytocin- and corticotropin-releasing hormone- synthesizing neurons in the rat paraventricular nucleus. Neuroscience, 91, 639-649.
382. Sanghera, M.K., German, D.C. (1983) The effects of benzodiazepine and non-benzodiazepine anxiolytics on locus coerulcus unit activity. J. Neural. Transm., 57, 267-279.
383. Saper, C.B., Scammell, T.E. (2004) Modafinil: A drug in search of a mechanism. Sleep, 27, 11-12.
384. Saper, C.B., Scammell, T.E., Lu, J. (2005) Hypothalamic regulation of sleep and circadian rhythms. Nature, 437, 1257-1263.
385. Sasa, M., Yoshimura, N. (1994) Locus coeruleus noradrenergic neurons as a micturition center. Microsc. Res. Tech., 29, 226-230.
386. Sasaki, M., Shibata, E., Tohyama, K., Takahashi, J., Otsuka, K., Tsuchiya, K., Takahashi, S., Ehara, S., Terayama, Y., Sakai, A. (2006) Neuromelanin magnetic resonance imaging of locus coeruleus and substantia nigra in Parkinson's disease. Neuroreport, 17, 1215-1218.
387. 2. Proc. Natl. Acad. Sci. USA, 95, 7754-7759.
388. Scheinin, M., Kallio, A., Koulu, M., Viikari, J., Scheinin, H. (1987) Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2- adrenoceptor agonist, in healthy volunteers. Br. J Clin. Pharmacol., 24, 443-451.
389. Scherder, E.J., Luijpen, M.W., Dijk, K.R. (2003) Activation of the dorsal raphe nucleus and locus coeruleus by transcutaneous electrical nerve stimulation in Alzheimer's disease: a reconsideration of stimulation- parameters derived from animal studies. Chin. J. Physiol., 46, 143-150.
390. Schmid, R., Ccurremans, P., Luedtke, H., Wilhelm, B.J., Wilhelm, H.M. (2004) Effect of age on the pupillornotor field. J. Neuroopthalmol., 24, 228-234.
391. Scinto, L.F., Daffner, K.R., Dressler, D., Ransil, B., Rentz, D., Weintraub, S., Mesulam, M., Potter, H. (1994) A potential non-invasive neurobilogical test for Alzheimer's disease. Science, 266, 1051-1054.
392. Scinto, L.F., Wu, C.K., Firla, K.M., Daffner, K.R., Saroff, D., Geula, C. (1999) Focal pathology in the Edinger-Westphal nucleus explains pupillary hypersensitivy in Alzheimer's disease. Acta Neuropathol (Berl), 97, 557-564.
393. 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case report. Eur. J. Clin. Pharmacol., 41, 593-596.
394. Senba, E., Matsunaga, K., Tohyama, M., Noguchi, K. (1993) Stress-induced c-fos expression in the rat brain: activation mechanism of sympathetic pathway. Brain Res. Bull., 31, 329-341.
395. Seutin, V., Franchimont, N., Massotte, L., Dresse, A. (1990) Comparison of the effect of morphine on locus coeruleus noradrenergic and ventral tegmental area dopaminergic neurons in vitro. Life Sci., 46, 1879-1885.
396. Sharpe, L.G., Pickworth, W.B. (1985) Opposite pupillary size effects in the cat and dog after microinjections of morphine, normorphine and clonidine in the Edinger-Westphal nucleus. Brain Res. Bull., 15, 329-333.
397. Shelly, M.P., Park, G.R. (1984) Morphine toxicity with dilated pupils. Br. Med. 1, 289, 1071-1072.
398. Shibasaki, T., Tsumori, C., Hotta, M., Imaki, T., Yamanda, K., Demura, H. (1995) The response pattern of noradrenaline release to repeated stress in the hypothalamic paraventricular nucleus differs according to the form of stress in rats. Brain Res., 670, 169-172.
399. Shibata, E., Sasaki, M., Tohyama, K., Kanbara, Y., Otsuka, K., Ehara, S., Sakai, A. (2006) Age-related changes in locus coeruleus on neuromelanin magnetic resonance imaging at 3 tesla. Magn. Reson. Med. Sci., 5, 197-200.
400. Shibata, E., Sasaki, M., Tohyama, K., Otsuka, K., Sakai, A. (2007) Reduced signal of locus cocruleus in depression in quantitative neuromelanin magnetic resonance imaging. Neuro Report, 18, 415-418.
401. Shih, C.-D., Chan, S.H.H., Chan, J.Y.H. (1995) Participation of hypothalamic paraventricular nucleus in locus coeruleus-induced baroreflex suppression in rats. Am. J. Physiol., 269, H46-H52.
402. Shimizu-Sasamata, M., Yamamoto, M., Harada, M. (1993) Cerebral activating properties of indeloxazine HC1 and its optical isomers. Pharmacol. Biochem. Behav., 45, 335-341.
403. Shirokawa, T., Ishida, Y., Isobe, K. (2000) Age-dependent changes in axonal branching of single locus coerulcus neurons projecting to two different terminal fields. J. Neurophysiol., 84, 1120-1122.
404. Shirokawa, T., Ishida, Y., Isobe, K. (2000) Changes in electrophysiological properties of axon terminals of locus coeruleus neuron with age in F344 rat. Neurosci. Lett., 289, 69-71.
405. Shirokawa, T., Ishida, Y., Isobe, K. (2003) Age-related changes in the release and uptake activity of presynaptic axon terminals of rat locus coeruleus neurons. Neurosci. Lett., 344, 212-214.
406. Shore, P.A. (1962) Release of serotonin and catecholamines by drugs. Pharmacol. Rev., 14, 531-550.
407. Shur, E., Checkley, S. (1982) Pupil studies in depressed patients: an investigation of the mechanism of action of desipramine. Br. J. Psychiatry, 140, 181-184.
408. Silva, R.C., Cruz, A.P., Avanzi, V., Landeira-Fernandez, J., Brandao, M.L. (2002) Distinct contributions of median raphe nucleus to contextual fear conditioning and fear-potentiated startle. Neural Plast., 9, 233-247.
409. Simson, P.E., Weiss, J.M. (1987) Alpha-2 receptor blockade increases responsiveness of locus coerulcus neurons to excitatory stimulation. J. Neurosci., 7, 1732-1740.
410. Simson, P.E., Weiss, J.M. (1989) Peripheral, but not local or intracerebroventricular, administration of benzodiazepines attenuates evoked activity of locus coeruleus neurons. Brain Res., 490, 236-242.
411. Singewald, N., Kaehler, S.T., Philippu, A. (1999) Noradrenaline release in the locus coeruleus of conscious rats is triggered by drugs, stress and blood pressure changes. Neuroreport, 10, 1583-1587.
412. Singewald, N., Philippu, A. (1998) Release of neurotransmitters in the locus coerulcus. Prog. Neurobiol., 56, 237-267.
413. Singewald, N., Sharp, T. (2000) Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunochemistry. Neuroscience, 98, 759-770.
414. Sjögren, M.J., Hellström, P.T., Jonsson, M.A., Runnerstam, M., Silander, H.C., Ben-Menachem, E. (2002) Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. J. Clin. Psychiatry, 63, 972-980.
415. Smiley, J.F., Subramanian, M., Mesulam, M.M. (1999) Monoaminergic- cholinergic interactions in the primate basal forebrain. Neuroscience, 93, 817-829.
416. Smith, S.A. (1992) Pupil function: tests and disorders. In: Bannister, R., Mathias, C.J. Eds. Autonomic Failure, Third Ed. Oxford University Press, Oxford, pp. 393-412.
417. Smith, A., Brice, C., Nash, J., Rich, N., Nutt, D.J. (2003) Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular function. J. Psychopharmacol., 17, 283-292.
418. Smith, M.S., Schambra, U.B., Wilson, K.H., Page, S.O., Hulette, C., Light, A.R., Schwinn, D.A. (1995) Alpha 2-adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha 2-adrenergic receptor subtypes at four distinct levels. Brain Res. Mol. Brain Res., 34, 109-117.
419. Spencer, S.E., Sawyer, W.B., Wada, H., Platt, K.B., Loewy, A.D. (1990) CNS projections to the pterygopalatine parasympathetic preganglionic neurons in the rat: a retrograde transneuronal viral cell body labeling study. Brain Res., 534, 149-169.
420. Spencer, SI, Buller, K.M., Day, T.A. (2005) Medial prefrontal cortex control of the paraventricular hypothalamic nucleus response to psychological stress: possible role of the bed nucleus of the stria terminalis. J. Comp. Neurol., 481, 363-376.
421. Spiegel, R., DeVos, J.E. (1980) Central effects of guanfacine and, clonidine during wakefulness and sleep in healthy subjects. Br. J. Clin. Pharmacol., 10 (Suppl. 1), 165S-168S.
422. Spyer, K.M. (1992) Central nervous control of the cardiovascular system. In: Bannister, R., Mathias, C.J. Eds. Autonomic Failure, 3rd Edition. Oxford, Oxford University Press, pp. 54-77.
423. Sridharan, G.V., Tallis, R.C., Leatherbarrow, B., Forman, W.M. (1995) A community survey of ptosis of the eyelid and pupil size of elderly people. Age Aging, 24, 21-24.
424. Srinivasan, J., Schmidt, W.J. (2003) Potentiation of parkinsonian symptoms by depiction of locus coerulcus noradrenaline in 6-hydroxydopamine- induced partial degeneration of substantia nigra in rats. Eur. J. Neurosci., 17, 2586-2592.
425. Srinivasan, J., Schmidt, W.J. (2004) Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2- bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease. Behav. Brain Res., 151, 191-199.
426. Steinhauer, S.R., Condray, R., Kasparek, A. (2000) Cognitive modulation of midbrain function: task-induced reduction of the pupillary light reflex. Int. J. Psychophysiol., 39, 21-30.
427. Steinhauer, S.R., Siegle, G.J., Condray, R., Pless, M. (2004) Sympathetic and parasympathetic innervation of pupillary dilation during sustained processing. Int. J. Psychophysiol., 52, 77-86.
428. Sterpenich, V., D'Argembeau, A., Desseilles, M., Balteau, E., Albouy, G., Vandewalle, G., Degueldre, C., Luxen, A., Collette, F., Maquet, P. (2006) The locus ceruleus is involved in the successful retrieval of emotional memories in humans. J. Neurosci., 26, 7416-7423.
429. Stock, G., Rupprecht U., Stumpf, H., Schlor, K.H. (1981) Cardiovascular changes during arousal elicited by stimulation of amygdala, hypothalamus and locus cocruleus. J. Auton. Nerv. Syst., 3, 503-510.
430. Stone, E.A., Quartermain, D., Lin, Y., Lehmann, M.L. (2007) Central - adrenergic system in behavioural activity and depression. Biochem. Pharmacol., 73, 1063-1075.
431. Straub, R.H., Thies, U., Kerp, L. (1992) The pupillary light reflex. 1. Age- dependent and age-independont parameters in normal subjects. Ophthalmologica, 204, 134-142.
432. Strange, P.G. (2001) Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol. Rev., 53, 119-134.
433. Strong, R., Huang, J.S., Huang, S.S., Chung, H.D., Hale, C., Burke, W.J. (1991) Degeneration of the cholinergic innervation of the locus coeruleus in Alzheimer's disease. Brain Res., 542, 23-28.
434. Sturrock, R.R., Rao, K.A. (1985) A quantitative histological study of neuronal loss from the locus cocrulcus if ageing mice. Neuropathol. Appl. Neurobiol., 11, 55-60.
435. Sugiyama, H., Hainfellner, J.A., Schmid-Siegel, B., Budka, H. (1993) Neuroaxonal dystrophy combined with diffuse Lewy body disease in a young adult. Clin. Neuropathol., 12, 147-152.
436. Sulser, F., Bass, A.D. (1968) Pharmacodynamic and biochemical considerations on the mode of action of reserpine-like drugs. In: Efron, D.H., Cole, J.O., Levine, J., Wittenborn, J.R. Eds. Psychopharmacology: A Review of Progress 1957-1967. USA, A Public Health Service Publication Number 1836. pp. 1093-1100.
437. Sun, M.K. (1992) Medullospinal vasomotor neurones mediate hypotension from stimulation of prefrontal cortex. J. Auton. Nerv. Syst., 38, 209-217.
438. Svensson, T.H., Almgren, O., Dahlof, C., Elam, M., Engberg, G., Hallberg, H., Thoren, P. (1980) Alpha and beta-adrenoreceptor-mediated control of brain noradrenaline neurons and antihypertensive therapy. Clin. Sci. (Lond.), 59 (Suppl 6), 479s-481s.
439. Svensson, T.H., Bunney, B.S., Aghajanian, G.K. (1975) Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res., 92, 291-306.
440. Swanson, L.W., Sawchenko, P.E. (1980) Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology, 31, 410-417.
441. Swanson, L.W., Sawchenko, P.E. (1983) Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Ann. Rev. Neurosci., 6, 269-324.
442. Szabadi, E. (2006) Drugs for sleep disorders: mechanisms and therapeutic prospects. Br. J. Clin. Pharmacol. 61, 761-766.
443. Szabadi, E., Bradshaw, C.M. (1988) Biological markers for anxiety state. In: Granville-Grosman, K. Ed, Recent Advances in Clinical Psychiatry (Volume 6). Edinburgh, Churchill Livingstone. pp. 69-99.
444. 2- adrenoceptors. J. Psychopharmacol., 10 (supp 3), 6-18.
445. Szabadi, E., Bradshaw, C.M. (2000) Mechanisms of action of reboxetine. Rev. Contemp. Pharmacother., 11, 267-282.
446. Szabadi, E., Tavernor, S. (1999) Hypo- and hypersalivation induced by psychoactive drugs. Incidence, mechanisms and therapeutic implications. CNS Drugs, 11, 449-466.
447. Szabo, B., Fröhlich, R., Illes, P. (1996) No evidence for functional imidazolinc receptors on locus coeruleus neurons. Naunyn-Schmiedebergs Arch. Pharmacol., 353, 557-563.
448. Szot, P., White, S.S., Greenup, J.L., Leverenz, J.B., Peskind, E.R., Raskind, M.A. (2006) Compensatory changes in the noradrenergic nervous system in the locus coerulcus and hippocampus of post-mortem subjects with Alzheimer's disease and dementia with Lewy bodies. J. Neurosci., 26, 467-478.
449. Takimoto, G.S., Stittsworth, J.D., Bianchi, B.R., Stephens, J.K. (1983) Differential sensitivity of hypothalamic norepincphrine and striatal dopamine to catecholamine-depleting agents. J. Pharmacol. Exp. Ther., 226, 432-439.
450. Tallarida, R.J., Kramer, M.S., Roy, J.W., Kester, R.A., Murray, R.B., Adler, M.W. (1977) Miosis and fluctuations in the rabbit pupil: effects of morphine and naloxone. J. Pharmacol. Exp. Ther., 201, 587-592.
451. Talley, E.M., Rosin, D.L., Lee, A., Guyenet, P.G., Lynch, K.R. (1996) Distribution of alpha 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. Comp. Neurol., 372, 111-134.
452. Tan, E.K. (2003) Piribedil-induced sleep attacks in Parkinson's disease. Fundam. Clin. Pharmacol., 17, 117-119.
453. Tanaka, M., Yoshida, M., Emoto, H., Ishii, H. (2000) Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur. J. Pharmacol., 405, 397-406.
454. Tassorelli, C., Micieli, G., Osipova, V., Rossi, F., Nappi, G. (1995) Pupillary and cardiovascular responses to the cold-pressor test. J. Auton. Nerv. Syst., 55, 45-49.
455. Tavernor, S.J., Abduljawad, K.A., Langley, R.W., Bradshaw, C.M., Szabadi, E. (2000) Effects of pentagastrin and the cold pressor test on the acoustic startle response and pupillary function in man. J. Psychopharmacol., 14, 387-394.
456. Tejani-Butt, S.M., Ordway, G.A. (1992) Effect of age on [3H]nisoxetine binding to uptake sites for norepinephrine in the locus coeruleus of humans. Brain Res., 583, 312-315.
457. Ter Horst, G.J., Toes, G.J., Van Willigen, J.D. (1991) Locus coeruleus projections to the dorsal motor vagus nucleus in the rat. Neuroscience, 45, 153-160.
458. Thase, M.E., Tran, P.V., Wiltse, C., Pangallo, B.A., Mallinckrodt, C., Detke, M.J. (2005) Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. J. Clin. Psychopharmacol., 25, 132-140.
459. Theofilopoulos, N., McDade, G., Szabadi, E., Bradshaw, C.M. (1995) Effects of reboxetine and desipramine on the kinetics of the pupillary light reflex. Br. J. Clin. Pharmacol., 39, 251-255.
460. Tomlinson, B.E., Irving, D., Blessed, G. (1981) Cell loss in the locus coeruleus in senile dementia of Alzheimer's type. J. Neurol. Sci., 49, 419-428.
461. Tsoucaris-Kupfer, D., Schmitt, H. (1972) Hypothermic effect of alpha- sympathomimetic agents and their antagonism by adrenergic and cholinergic blocking drugs. Neuropharmacology, 11, 625-635.
462. Tsuruoka, M., Matsutani, K., Maeda, M., Inoue, T. (2003) Coeruleotrigeminal inhibition of nociceptive processing in the rat trigeminal subnucleus caudalis. Brain Res., 993, 146-153.
463. Ulivelli, M., Rossi, S., Lombardi, C., Bartalini, S., Rocchi, R., Giannini, F., Passero, S., Battistini, N., Lugaresi, E. (2002) Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Neurology, 58, 462-465.
464. Umemura, T., Ueda, K., Nishioka, K., Hidaka, T., Takemoto, H., Nakamura, S., Jitsuiki, D., Soga, J., Goto, C., Chayama, K., Yoshizumi, M., Higashi, Y. (2006) Effects of acute administration of caffeine on vascular function. Am. J. Cardiol., 98, 1538-1541.
465. Unnerstall, J.R., Kopajtic, T.A., Kuhar, M.J. (1984) Distribution of alpha 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res., 319, 69-101.
466. Urade, Y., Eguchi, N., Qu, W.M., Sakata, M., Huang, Z.L., Chen, J.F., Schwarzschild, M.A., Fink, J.S., Hayaishi, O. (2003) Sleep regulation in adenosine A(2A) receptor-deficient mice. Neurology, 61 (11 Suppl 6), S94-S96.
467. Uschakov, A., Gong, H., McGinty, D., Szymusiak, R. (2006) Sleep-active neurons in the preoptic area project to the hypothalamic paraventricular nucleus and perifornical lateral hypothalamus. Eur. J. Neurosci., 23, 3284-3296.
468. U.S. Modafinil in Narcolepay Multicentre Study Group. (1998) Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann. Neurol., 43, 88-97.
469. U.S. Modafinil in Narcolepsy Multicentre Study Group. (2000) Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology, 54, 1166-1175.
470. Van Bockstaele, E.J., Pieribone, V.A., Aston-Jones, G. (1989) Diverse afferents converge on the nucleus paragigantocellularis in the rat ventrolateral medulla: retrograde and anterograde tracing studies. J. Comp. Neurol., 290, 561-584.
471. VanderMaelen, C.P., Aghajanian, G.K. (1980) Intracellular studies showing modulation of facial motoneurone excitability by serotonin. Nature, 287, 346-347.
472. van Dongen, P.A. (1981) The central noradrenergic transmission and the locus coeruleus: a review of the data, and their implications for neurotransmission and neuromodulation. Prog. Neurobiol., 16, 117-143.
473. van Steveninck, A.L., van Berckel, B.N., Schoemaker, R.C., Breimer, D.D., van Gerven, J.M., Cohen, A.F. (1999) The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation. J. Psychopharmacol., 13, 10-17.
474. 2-adrenoceptor blockade in the rat. Eur. J. Pharmacol., 453, 287-297.
475. Verleye, M., Bernet, F. (1983) Behavioural effects of lesions of the central noradrenergic bundle in the rat. Pharmacol. Biochem. Behav., 19, 407-414.
476. Verster, J.C., Veldhuijzen, D.S., Volkerts, E.R. (2006) Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. Clin. J. Pain, 22, 499-504.
477. Vijayashankar, N., Brody, H. (1979) A quantitative study of the pigmented neurons in the nuclei locus coeruleus and subcoeruleus in man as related to aging. J. Neuropathol. Exp. Neurol., 38, 490-497.
478. Voisin, D.L., Guy, N., Chalus, M., Dallel, R. (2005) Nociceptive stimulation activates locus coeruleus neurones projecting to the somatosensory thalamus in the rat. J. Physiol., 566, 929-937.
479. Walker, D.J., Zacny, J.P. (1998) Subjective, psychomotor, and analgesic effects of oral codeine and morphine in healthy volunteers. Psychopharmacology (Berl.), 140, 191-201
480. Walsh, J.K., Randazzo, A.C., Stone, K.L., Schweitzer, P.K. (2004) Modafinil improves alertness, vigilance, and executive function during simulated night shifts. Sleep, 27, 434-439.
481. Walter, H., Lesch, O.M., Stohr, H., Grunberger, J., Gutierrez-Lobos, K. (2005) Reaction to pain stimulus before and during hypnosis measured by pupillary reaction. Am. J. Clin. Hypn., 48, 145-152.
482. Ward, D.G., Gunn, C.G. (1976) Locus coeruleus complex: elicitation of a pressor response and a brain stem region necessary for its occurrence. Brain Res., 107, 401-406.
483. 2-adrenoceptor antagonist, with use of intravenous clonidine. Clin. Pharmacol. Ther., 46, 103-109.
484. Watson, C.J., Lydic, R., Baghdoyan, H.A. (2007) Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine. Neuroscience, 144, 375-386.
485. Webster, L., Andrews, M., Stoddard, G. (2003) Modafinil treatment of opioid-induced sedation. Pain Med., 4, 135-140.
486. Weerasuriya, K., Shaw, E., Turner, P. (1984) Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males. Eur. J. Clin. Pharmacol., 27, 281-286.
487. Werling, L.L., Brown, S.R., Cox, B.M. (1987) Opioid receptor regulation of the release of norepinephrine in brain. Neuropharmacology, 26, 987-996.
488. Wesensten, N.J., Killgore, W.D.S., Balkin, T.J. (2005) Performance and alertness of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J. Sleep Res., 14, 255-266.
489. Westlund, K.N., Bowker, R.M., Ziegler, M.G., Coulter, J.D. (1983) Noradrenergic projections to the spinal cord of the rat. Brain Res., 263, 15-31.
490. Westlund, K.N., Coulter, J.D. (1980) Descending projections of the locus coeruleus and subcoeruleus/medial parabrachial nuclei in monkey: axonal transport studies and dopamine-beta-hydroxylase immunocytochemistry. Brain Res., 2, 235-264.
491. White, S.R., Fung, S.J., Barnes, C.D. (1991) Norepinephrine effects on spinal motoneurons. Prog. Brain Res., 88, 343-350.
492. White, S.M., Lambe, C.J.T. (2003) The pathophysiology of cocaine abuse. J. Clin. Forensic Med., 10, 27-39.
493. Wilhelm, B., Giedke, H., Lüdtke, H., Bittner, E., Hofmann, A., Wilhelm, H. (2001) Daytime variations in central nervous system activation measured by a pupillographic sleepiness test. J. Sleep Res., 10, 1-7.
494. Williams, J.T., Henderson, G., North, R.A. (1985) Characterization of alpha 2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurones. Neuroscience, 14, 95-101.
495. Williams, J., Lacey, M. (1988) Actions of cocaine on central monoamine neurons: intracellular recordings in vitro. NIDA Res. Monogr., 90, 234-242.
496. Williams, J.T., North, R.A. (1985) catecholamine inhibition of calcium action potentials in rat locus coeruleus neurones. Neuroscience, 14, 103-109.
497. Wilson, M.C., Bedford, J.A., Buelke, J., Kibbe, A.H. (1976) Acute pharmacological activity of intravenous cocaine in the rhesus monkey. Psychopharmacol. Commun., 2, 251-261.
498. Winslow, J.T., Parr, L.A., Davis, M. (2002) Acoustic startle, prepulse inhibition, and fear-potentiated startle measured in rhesus monkeys. Biol. Psychiatry, 51, 859-866.
499. Wisor, J.P., Nishino, S., Sora, I., Uhl, G.H., Mignot, E., Edgar, D.M. (2001) Dopaminergic role in stimulant-induced wakefulness. J. Neurosci., 21, 1787-1794
500. Wright, K.P. Jr., Badia, P., Myers, B.L., Plenzler, S.C., Hakel, M. (1997) Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans. Brain Res., 747, 78-84.
501. Yaïci, E.-D., Rampin, O., Calas, A., Jestin, A., McKenna, K.E., Leclerc, P., Benoit, G., Giuliano, F. (2002) α2a and α2c adrenoceptors on spinal neurons controlling pende erection. Neuroscience, 114, 945-960.
502. Yaksh, T.L., Provencher, J.C., Rathbun, M.L., Myers, R.R., Powell, H., Richter, P., Kohn, F.R. (2000) Safety assessment of encapsulated morphine delivered epidurally in a sustained-release multivesicular liposome preparation in dogs. Drug Deliv., 7, 27-36.
503. Yang, Y., Beyreuther, K., Schmitt, H.P. (1999) Spatial analysis of the neuronal density of aminergic brainstem nuclei in primary neurodegenerative and vascular dementia: a comparative immunocytochemical and quantitative study using a graph method. Anal. Cell Pathol., 19, 125-138.
504. Yang, L.L., Niemann, C.U., Larson, M.D. (2003) Mechanism of pupillary reflex dilation in awake volunteers and in organ donors. Anesthesiology, 99, 1281-1286.
505. Yeomans, J.S., Frankland, P.W. (1996). The acoustic startle reflex: neurons and connections. Brain Res. Brain Res. Rev., 21, 301-314.
506. Yoshimura, N., Sasa, M., Yoshida, O., Takaori, S. (1990) Alpha 1-adrenergic receptor-mediated excitation from the locus coeruleus of the sacral parasympathetic preganglionic neuron. Life Sci., 47, 789-797.
507. Yoss, R.E., Moyer, N.J., Hollenhurst, R.W. (1970) Pupil size and spontaneous pupillary waves associated with alertness, drowsiness, and sleep. Neurology, 20, 545-554.
508. Yuan, L., Brewer, C., Pfaff, D. (2002) Immediate-early Fos protein levels in brainstem neurons of male and female gonadectomized mice subjected to cold exposure. Stress, 5, 285-294.
509. Zaborszky, L., Cullinan, W.E., Luine, V.N. (1993) Catecholamine-cholinergic interaction in the basal forebrain. Prog. Brain Res., 98, 31-49.
510. Zaccara, G., Gangemi, P.F., Muscas, G.C., Paganini, M., Pallanti, A., Parigi, A., Messori, A., Arnetoli, G. (1992) Smooth-pursuit eye movements: alterations in Alzheimer's disease. J. Neurol. Sci., 112, 81-89.
511. Zacny, E. (1982) The role of alpha-2-adrenoceptors in the hypothermic effect of clonidine in the rat. J. Pharm. Pharmacol., 34, 455-456.
512. Zacny, J.P. (2005) Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users. Drug Alcohol Depend., 80, 273-278.
513. Zamir, N., Palkovits, M., and Brownstein, M.J. (1984) The distribution of immunoreactive α-neo-endorphin in the central nervous system of the rat. J. Neurosci., 4, 1240-1247.
514. Zarow, C., Lyness, S.A., Mortimer, J.A., Chui, H.C. (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch. Neurol., 60, 337-341.
515. Zecca, L., Tampellini, D., Gerlach, M., Riederer, P., Farielló, R.G., Sulzer, D. (2001) Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. J. Clin. Pathol. Mol. Pathol., 54, 414-418.
516. Zheng, G., Dwoskin, L.P., Crooks, P.A. (2006) Vesicular monoamine transporter 2: role as a novel target for drug development. AAPS J., 8, E682-E692.
517. Zhou, J. (2004) Norepinephrine transporter inhibitors and their therapeutic potential. Drugs Future, 29, 1235-1244.
518. Zhu, H., Zhou, W. (2001) Morphine induces synchronous oscillatory discharges in the rat locus coeruleus. J. Neurosci., 21, RC179 (1-5).
519. Zucca, F.A., Bellei, C., Giannelli, S., Terreni, M.R., Gallorini, M., Rizzio, E., Pezzoli, G., Albertini, A., Zecca, L. (2006) Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. J. Neural Transm., 113, 757-767.
520. Zweig, R.M., Cardillo, J.E., Cohen, M., Giere, S., Hedreen, J.C. (1993) The locus coeruleus and dementia in Parkinson's disease. Neurology, 43, 986-991.
521. Zweig, R.M., Ross, C.A., Hedreen, J.C., Peyser, C., Cardillo, J.E., Folstein, S.E., Price, D.L. (1992) Locus coeruleus involvement in Huntington's disease. Arch. Neurol., 49, 152-156.
522. Zwyghuizen-Doorenbos, A., Roehrs, T.A., Lipschutz, L., Timms, V., Roth, T. (1990) Effects of caffeine on alertness. Psychopharmacology (Berl.), 100, 36-39.